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A B S T R A C T
Background
Traumatic wounds (wounds caused by injury) range from abrasions and minor skin incisions or tears, to wounds with extensive tissue
damage or loss as well as damage to bone and internal organs. Two key types of traumatic wounds considered in this review are
those that damage soft tissue only and those that involve a broken bone, that is, open fractures. In some cases these wounds are left
open and negative pressure wound therapy (NPWT) is used as a treatment. This medical device involves the application of a wound
dressing through which negative pressure is applied and tissue fluid drawn away from the area. The treatment aims to support wound
management, to prepare wounds for further surgery, to reduce the risk of infection and potentially to reduce time to healing (with or
without surgical intervention). There are no systematic reviews assessing the effectiveness of NPWT for traumatic wounds.
Objectives
To assess the effects of NPWT for treating open traumatic wounds in people managed in any care setting.
Search methods
In June 2018 we searched the CochraneWounds Specialised Register, the Cochrane Central Register of Controlled Trials (CENTRAL),
OvidMEDLINE (including In-Process &OtherNon-Indexed Citations), Ovid Embase and EBSCOCINAHL Plus.We also searched
clinical trials registries for ongoing and unpublished studies, and scanned reference lists of relevant included studies as well as reviews,
meta-analyses and health technology reports to identify additional studies. There were no restrictions with respect to language, date of
publication or study setting.
Selection criteria
Published and unpublished randomised controlled trials that used NPWT for open traumatic wounds involving either open fractures
or soft tissue wounds. Wound healing, wound infection and adverse events were our primary outcomes.
Data collection and analysis
Two review authors independently selected eligible studies, extracted data, carried out a ’Risk of bias’ assessment and rated the certainty
of the evidence. Data were presented and analysed separately for open fracture wounds and other open traumatic wounds (not involving
a broken bone).
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Main results
SevenRCTs (1377 participants recruited)met the inclusion criteria of this review. Study sample sizes ranged from40 to 586 participants.
One study had three arms, which were all included in the review. Six studies compared NPWT at 125 mmHg with standard care: one
of these studies did not report any relevant outcome data. One further study compared NPWT at 75 mmHg with standard care and
NPWT 125mmHg with NPWT 75 mmHg.
Open fracture wounds (four studies all comparing NPWT 125 mmHg with standard care)
One study (460 participants) comparing NPWT 125 mmHg with standard care reported the proportions of wounds healed in each
arm. At six weeks there was no clear difference between groups in the number of participants with a healed, open fracture wound: risk
ratio (RR) 1.01 (95% confidence interval (CI) 0.81 to 1.27); moderate-certainty evidence, downgraded for imprecision.
We pooled data on wound infection from four studies (596 participants). Follow-up varied between studies but was approximately 30
days. On average, it is uncertain whether NPWT at 125 mmHg reduces the risk of wound infection compared with standard care (RR
0.48, 95% CI 0.20 to 1.13; I2 = 56%); very low-certainty evidence downgraded for risk of bias, inconsistency and imprecision.
Data from one study shows that there is probably no clear difference in health-related quality of life between participants treated with
NPWT 125 mmHg and those treated with standard wound care (EQ-5D utility scores mean difference (MD) -0.01, 95% CI -0.08 to
0.06; 364 participants, moderate-certainty evidence; physical component summary score of the short-form 12 instrument MD -0.50,
95% CI -4.08 to 3.08; 329 participants; low-certainty evidence downgraded for imprecision).
Moderate-certainty evidence from one trial (460 participants) suggests that NPWT is unlikely to be a cost-effective treatment for
open fractures in the UK. On average, NPWT was more costly and conferred few additional quality-adjusted life years (QALYs) when
compared with standard care. The incremental cost-effectiveness ratio was GBP 267,910 and NPWT was shown to be unlikely to be
cost effective at a range of cost-per-QALYs thresholds. We downgraded the certainty of the evidence for imprecision.
Other open traumatic wounds (two studies, one comparing NPWT 125 mmHg with standard care and a three-arm study comparing NPWT
125 mmHg, NPWT 75 mmHg and standard care)
Pooled data from two studies (509 participants) suggests no clear difference in risk of wound infection between open traumatic wounds
treated with NPWT at 125 mmHg or standard care (RR 0.61, 95% CI 0.31 to 1.18); low-certainty evidence downgraded for risk of
bias and imprecision.
One trial with 463 participants compared NPWT at 75 mmHg with standard care and with NPWT at 125 mmHg. Data on wound
infection were reported for each comparison. It is uncertain if there is a difference in risk of wound infection between NPWT 75
mmHg and standard care (RR 0.44, 95% CI 0.17 to 1.10; 463 participants) and uncertain if there is a difference in risk of wound
infection between NPWT 75 mmHg and 125 mmHg (RR 1.04, 95% CI 0.31 to 3.51; 251 participants. We downgraded the certainty
of the evidence for risk of bias and imprecision.
Authors’ conclusions
There is moderate-certainty evidence for no clear difference between NPWT and standard care on the proportion of wounds healed
at six weeks for open fracture wounds. There is moderate-certainty evidence that NPWT is not a cost-effective treatment for open
fracture wounds. Moderate-certainty evidence means that the true effect is likely to be close to the estimate of the effect, but there is a
possibility that it is substantially different. It is uncertain whether there is a difference in risk of wound infection, adverse events, time
to closure or coverage surgery, pain or health-related quality of life between NPWT and standard care for any type of open traumatic
wound.
P L A I N L A N G U A G E S U M M A R Y
Negative pressure wound therapy for open traumatic wounds
What is the aim of this review?
The aim of this review was to find out whether negative pressure wound therapy (NPWT) (a sealed wound dressing connected to a
vacuum pump that sucks up fluid from the wound) is effective for treating open traumatic wounds (injuries such as animal bites, bullet
wounds or fractures that result in bone piercing the skin to form open wounds). Researchers from Cochrane collected and analysed all
relevant studies (randomised controlled trials) to answer this question and found seven relevant studies.
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Key messages
We cannot be certain whether NPWT is effective for treating traumatic wounds. We are moderately confident that there is no clear
difference in healing rates in open fracture wounds treated with NPWT compared with standard care. We are very uncertain whether
people treated with NPWT experience fewer wound infections compared with those treated with standard care. There is moderate-
certainty evidence that NPWT is not a cost-effective treatment for open fracture wounds.
What was studied in the review?
Traumatic wounds are open cuts, scrapes or puncture wounds, where both the skin and underlying tissues are damaged. These wounds
may have jagged edges and contain items such as gravel or glass. Injuries caused by road traffic accidents, stab and gunshot wounds,
and animal bites are common types of traumatic wound.
NPWT is a treatment that is used widely on different types of wounds. In NPWT, a machine that exerts carefully controlled vacuum
suction (negative pressure) is attached to a wound dressing that covers the wound. Wound and tissue fluid is sucked away from the
treated area into a canister. This is thought to increase blood flow and improve wound healing.
We wanted to find out if NPWT could help open traumatic wounds to heal more quickly and effectively.We wanted to know if people
treated with NPWT experienced any side effects or other complications, such as wound infections and pain. We were also interested
in the impact of NPWT on people’s quality of life.
What are the main results of the review?
We found seven relevant studies, dating from 2008-2017, which compared the effect of different strengths of NPWT with standard
wound care. The studies involved a total of 1381 participants aged 12 years and over. The participants’ sex was not recorded. Not all
the studies stated how they were funded. One was funded by an NPWT manufacturer.
There is no clear difference in healing rates in participants with open fracture wounds treated with NPWT compared with those
receiving standard care. There is moderate-certainty evidence that NPWT is not a cost-effective treatment for open fracture wounds.
We are very uncertain as to whether NPWT may reduce the likelihood of wound infection compared with standard care. There is no
clear evidence that NPWT impacts on people’s experience of pain, adverse events or their experience of receiving therapy.
How up to date is this review?
We searched for studies that had been published up to June 2018.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
NPWT 125 mmHg compared with standard care in open fracture wounds
Patient or population: open f racture wounds
Setting: orthopaedic ward
Intervention: NPWT 125 mmHg
Comparison: standard care (other dressings)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with standard care Risk with NPWT 125
mmHg
Complete wound heal-
ing
Follow-up: six weeks
397 per 1000 401 per 1000
(322 to 504)
RR 1.01 (0.81, 1.27) 460 (1 study) ⊕⊕⊕©
Moderate1
There is no clear dif f er-
ence
in number of wounds
healed between NPWT
125mmHg and stan-
dard care in open f rac-
ture wounds over 6
weeks of follow-up
Wound infection
Follow-up:
approximately 30 days,
with variat ion between
studies
178 per 1000 85 per 1000
( 36 to 201)
RR 0.48
(0.20, 1.13)
596 (4 studies) ⊕©©©
Very low2
It is uncertain whether
there are dif ferences
in risk of wound in-
fect ion between NPWT
125 mmHg and stan-
dard care
Adverse events
Follow-up up to 12
months
Not est imable Not est imable Not est imable 460 (1 study) n/ r Number of events pre-
sented: rather than data
by number of part ici-
pants
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Time to closure or cov-
erage surgery (days)
Follow-up: mean 23
weeks
The mean time to
surgery in the control
group ranged between
3.2 and 9.8 days
The mean time to
surgery in the control
group ranged between
4 and 8.3 days
- 151
(2 studies)
⊕©©©
Very low3
Measures of variance
were not reported. No
further analysis carried
out
Pain Not est imable Not est imable Not est imable Not est imable Not est imable
*The risk in the intervention group (and its 95% conf idence interval) is based on the median risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; n/ r: not reported; RR: risk rat io
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded one level for serious imprecision: the true ef fect could range f rom a 19% reduct ion in risk of wound healing to a
27% increase in the NPWT group.
2Downgraded three levels: once for serious risk of bias, once for serious imprecision and once for serious inconsistency.
3Downgraded three levels: once for serious risk of bias (no blind outcome assessment); once for very serious imprecision
with a small sample size and lim ited reported information to quant if y imprecision.
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B A C K G R O U N D
Description of the condition
The World Health Organization estimates that 5.8 million peo-
ple worldwide die annually from injuries (WHO 2014). These
deaths account for a small proportion of the overall number of
injured (Alexandrescu 2009). Traumatic wounds (wounds caused
by injury) range from abrasions and minor skin incisions or lac-
erations (tears), to wounds with extensive tissue damage or loss,
and may be associated with injury to underlying structures such as
bone, or viscera (internal organs) (DeBoard 2007; Edlich 2010).
The extent of tissue damage is influenced by the mechanism of
injury: traumatic wounds can be caused by blunt trauma, pene-
trating trauma (such as stabbing and gunshots), crush injury, blast
injury, burns, de-gloving injuries (in which an extensive layer of
skin is torn from the underlying tissue) and animal bites. Early
management of traumatic wounds is frequently dictated by the
need for urgent assessment and management of concomitant se-
vere, life-threatening injuries (Hollander 1995). Ongoing man-
agement of traumatic injuries is governed by the degree of dam-
age to underlying or associated structures and aims to preserve, or
restore, both function and form, thus minimising disability and
disfigurement. Some traumatic wounds will be closed or covered
with a skin graft or other reconstruction very quickly. These closed
traumatic wounds are not the focus of this review. Rather we focus
on those traumatic wounds that are left open for a period of time
rather than being closed immediately with surgery on admission
to hospital.
There is no current classification system for open traumatic
wounds beyond the general causes and structural involvement
listed above. For this review we will separately consider two
broad categories: open fracture wounds and other open traumatic
wounds.
Open fracture wounds
An open (or compound) fracture is a fracture accompanied by
an open wound at or near to the fracture site. The simultaneous
exposure of tissue and bone presents specific management chal-
lenges. As with most wounds, damage to the soft tissue increases
the risk of infection: however, prophylaxis against osteomyelitis
(bone infection) is also key factor in treatment. The severity of
open fractures is generally assessed using the Gustilo-Anderson
open fracture classification system, which considers wound size;
contamination and tissue damage (Gustilo 1976; Gustilo 1984).
Grade Definition
I Open fracture with a clean wound that is less than 1 cm in length
II Open fracture, without extensive soft-tissue damage, flaps, avulsions with a wound greater than 1 cm but less than 10 cm
in length
III An open fracture with extensive soft tissue damage; a traumatic amputation or an open segmental fracture. Can also include
specific categories of open fracture such as those caused by farm injuries, fractures requiring vascular repair, or fractures that
have been open for 8 hours prior to treatment
IIIA Type III fracture with adequate coverage of the fracture bone despite extensive soft-tissue damage
IIIB Type III fracture with extensive soft-tissue loss and periosteal stripping and bone damage (usually associated with massive
contamination)
IIIC Type III fracture associated with an arterial injury requiring repair
Standard treatment for open fracture is, where possible, the pro-
phylactic use of antibiotics, to prevent infection and surgical in-
tervention to clean the wound and debride (remove) devitalised
tissue. During surgery vascular and tissue repair may also be un-
dertaken and the fracture either internally or externally fixated
with metal pins. At the end of the surgery the wound might be
closed over the fracture, covered with reconstruction (e.g. a skin
graft) or left open. The decision to leave a wound open is normally
based on the extent of damage, the risk of infection and the po-
tential need for further surgery. Those wounds that are left open
will often undergo further surgical debridement with the aim of
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achieving wound closure or coverage as quickly as possible.
Other open traumatic wounds
Most trauma wounds are limited to soft tissue damage with no or
limited direct orthopaedic involvement in the wound. The sever-
ity of such wounds varies based on the extent of damage and the
anatomical location and corresponding internal organ involve-
ment. Treatment of these wounds varies but will generally involve
wound cleaning that ranges from local irrigation with saline so-
lution for minor cuts, abrasions and lacerations to surgical de-
bridement. Wounds may then be closed (e.g. with stitches), cov-
ered as part of reconstructive surgery (e.g. with a skin graft) or
left open in order for further surgery to be performed or for the
wound toheal by secondary intention (from the bottomup). Acute
traumatic wounds can be described as contaminated or dirty/in-
fected (dependent on the mechanism and area of the body in-
jured) (Mangram 1999). Older traumatic wounds that may have
retained devitalised (dead) tissue, those presenting with signs of
infection or involving infected material, and those involving per-
forated viscera (internal organs) can be described as dirty/infected
(Mangram 1999).
Description of the intervention
Negative pressure wound therapy (NPWT) is a technology that
is currently used widely in wound care and is promoted for use
on complex wounds (open wounds) (Guy 2012). NPWT involves
the application of a wound dressing through which a negative
pressure is applied, often with any wound and tissue fluid drawn
away from the area being collected into a canister. The amount of
pressure applied using the therapy can vary and there is no single
protocol for use, however, pressure being delivered ranges from 75
mmHg to 150 mmHg, with 125 mmHg being commonly used
(Peinemann 2011). The intervention was developed in the 1990s,
and the uptake of NPWT in the healthcare systems of developed
countries has been dramatic. A US Department of Health report
estimated that between 2001 and 2007, Medicare payments for
NPWT pumps and associated equipment increased fromUSD 24
million to USD 164 million (an increase of almost 600%) (HHS
2009). No national cost data is available for the UK. Initially only
one NPWTmanufacturer supplied NPWTmachines (the V.A.C.
system: KCI, San Antonio Texas), however, as the NPWT mar-
ket has grown, a number of different commercial NPWT sys-
tems have been developed, with machines becoming smaller and
more portable. Indeed, the most recent introduction to the mar-
ket is a single use, or ’disposable’, negative pressure product (e.g.
PICO: Smith & Nephew, UK). Ad hoc, non-commercial , nega-
tive pressure devices are also used, especially in resource-poor set-
tings. These devices tend to use simple wound dressings, such as
gauze, or transparent, occlusive (non-permeable) dressings, with
negative pressure generated in hospital by vacuum suction pumps.
A number of different healthcare professionals prescribe and ap-
ply NPWT, and it is now used both in secondary and primary
(community) care, particularly following the introduction of am-
bulatory systems. Whilst the NPWT systems outlined above dif-
fer in a number of respects - such as type of pressure (constant
or cyclical) applied to the wound, the material in contact with
the surface of the wound and also the type of dressing used - the
principle of applying a negative pressure to the wound in a closed
environment is the same for all products. The place of NPWT in
the treatment pathway and the rationale for its use vary based on
different types of traumatic wound and local treatment protocols.
For open fracture wounds that have been debrided but are still
waiting for soft tissue cover,National Institute forHealth andCare
Excellence (NICE) guidelines recommend that NPWT is consid-
ered as an intermediate wound dressing prior to further surgical
intervention. Thus, NPWT would be used for a short period of
time on an open, post-trauma/post-surgical wound, with a key
aim of reducing infection risk.
For more general soft tissue trauma wounds, the use of NPWT
can vary: the treatment may be used on open wounds with the aim
of promoting healing by secondary intention and also, potentially,
to ready a wound for further surgery as with open fractures.
How the intervention might work
NPWT is thought to facilitate wound healing via several different
mechanisms. The negative pressure exerted by the dressing causes
deformation of the wound, drawing the skin edges closer together
therefore reducing the volume of tissue and skin needed to heal
the wound (KCI Medical 2012). The pressure effects also cause
strain or tension across the tissue, which is thought to increase
capillary flow, ultimately stimulating granulation tissue formation
and growth of new blood vessels (Saxena 2004). Removal of high
volumes of wound exudate, containing enzymes and other pro-
teins involved in inflammation, may prevent further tissue dam-
age. Removal of this fluid also reduces the frequency of dressing
changes by keeping the surrounding skin dry, particularly around
anatomically-challenging wounds (for example around joints or
skin creases). Manufacturers have also suggested that NPWT re-
moves infected material, which may reduce the bacterial burden
that can delay healing and reconstructive surgery (KCI Medical
2012). The molecular effects of negative pressure on the wound
bed are still being investigated (Glass 2014).
There are some potentially negative aspects associated with
NPWT; these include wound maceration (softening due to pro-
longed exposure to liquid), retention of dressings, and wound in-
fection as well as other injuries (FDA 2011). NPWT devices are
usually worn continually by patients during treatment so they can
interfere with mobility, and, anecdotally, are often noisy, which
prevents some patients from sleeping. However there have been
some recent technological advances of smaller, more portable ma-
chines, which may reduce these issues and may also be more cost-
effective.
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Why it is important to do this review
It is important to assess current evidence regarding the clinical- and
cost-effectiveness of NPWT given its widespread use. Currently
consideration of the use of NPWT is recommended by NICE
guidelines as a treatment for open fracture wounds (NICE 2017).
There is limited guidance for the use of NPWTon trauma wounds
more widely. There is no recently published, high-quality review
on the use of NPWT for traumatic wounds. The aim of this review
is to inform decision makers and guide future research.
O B J E C T I V E S
To assess the effects of NPWT for treating open traumatic wounds
in people managed in any care setting.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We considered published and unpublished randomised controlled
trials (RCTs), including cluster RCTs, irrespective of language of
report. We planned to exclude cross-over trials, as they are not an
appropriate design in this context. We also intended to exclude
studies using quasi-randomisation.
Types of participants
We considered RCTs recruiting people (adults and children) de-
scribed in the primary report as having open traumatic wounds in-
volving either soft tissue wounds (including for example blunt de-
gloving injuries (where skin is completely torn off underlying tis-
sue) and gunshot wounds), or open fractures, managed in any care
setting, to be eligible for inclusion. We excluded RCTs recruiting
people with traumatic wounds due to burns (including exclusion
of blast-related injuries that are likely to be burns). As the method
of defining soft tissue traumatic wounds may vary, we intended
to accept definitions as used by the study authors. We excluded
studies that recruited participants with traumatic wounds along-
side people with other types of wounds, where randomisation did
not take wound type into account and data for traumatic wounds
were not presented separately. Studies on skin grafts and open ab-
domen were not eligible for inclusion. We also excluded studies
that recruited people with trauma wounds that were not treated
as open wounds prior to closure. These were considered solely to
be surgical wounds healing by primary intention and would be
included in the review focused on these wounds (Webster 2014).
Following publication of the protocol we decided, in collaboration
with further experts in the field, to present the results of the review
for populations with open fracture and with other types of open
traumatic wounds as separate sub-populations within this review.
This decision was based on differences in the wound types, wound
management protocols and differences in the use of NPWT in the
treatment pathway. (See How the intervention might work, Types
of interventions and Differences between protocol and review).
Types of interventions
The primary intervention of interest is NPWT (both commercial
and non-commercial treatments). We included RCTs in which
the use of a specific NPWT intervention during the treatment pe-
riod was the only systematic difference between treatment groups.
We anticipated that likely comparisons would include the use of
NPWT during the care pathway compared with no use of NPWT
or comparison of different types/brands of NPWT used during
the care pathway.
Types of outcome measures
We list primary and secondary outcomes below. If a study was
otherwise eligible (i.e. correct study design, population and inter-
vention/comparator) but did not report a listed outcome, then we
contacted the study authors where possible to establish whether
an outcome of interest here was measured but not reported.
We reported outcome measures at the latest time point available
(assumed to be length of follow-up if not specified) and the time
point specified in the methods as being of primary interest (if
this was different from latest time point available). For wound
infection we planned to class assessment of outcomes from:
• up to 30 days as short term;
• 31 days to 12 months as medium term;
• over 12 months as long term.
for all other outcomes we planned to class assessment of outcome
measures from:
• one week or less to eight weeks as short term;
• eight weeks to 16 weeks as medium term; and
• more than 16 weeks as long term.
Primary outcomes
The primary outcomes for this review are wound healing, wound
infection and adverse events.
Complete wound healing
For this reviewwe intended to regard the following as providing the
most relevant and rigorous measures of complete wound healing:
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• time to complete wound healing (we would have recorded
if this had been correctly analysed using censored data and with
adjustment for prognostic covariates such as baseline size);
• the proportion of wounds healed (frequency of complete
wound healing).
Hadboth outcomes above been reported,wewould have presented
all data in a summary outcome table for reference, but focused
on reporting time to wound healing. We planned to accept study
authors’ definitions of what constituted a healed wound.
Wound infection
Proportion of wounds infected (with infection as defined by study
authors). The inclusion of this outcome represents a change from
the protocol; seeDifferences betweenprotocol and review formore
details. We considered both superficial and deep infection within
this outcome. Traumatic wounds are at risk of contamination and
thus infection as soon as a wound is formed. Since trauma wounds
are often operated on shortly after their formation they are also at
risk from surgical site infection. Decisions about whether wound
infections were surgical or not surgical in origin were seldom re-
ported and any difference was not deemed important here; thus
we did not delineate between wound infection and surgical site
infection within this outcome.
Adverse events
We extracted reported data on adverse events that were classed as
’serious adverse events’ and ’non-serious adverse events’ where the
study provided a clear methodology for the collection of adverse
event data. We anticipated that the methodology should make
it clear whether events were reported at the participant level or,
where multiple events per person were reported, that an appropri-
ate adjustment was made for data clustering. We did not extract
individual types of adverse events such as pain or infection, which
require specific assessment under this outcome, rather we used the
assessment of any event classed as adverse by the participant or
health professional, or both, during the trial.
Secondary outcomes
• Proportion of wounds closed or covered with surgery:
complete wound closure as the result of delayed surgical closure
but without subsequent wound healing (that is, the wounds were
surgically closed but not yet healed).
• Time to closure or coverage surgery: NPWT is often not
used until complete wound healing but until a point where the
wound is ready for further treatment such as closure surgery.
• Participant health-related quality of life/health status
(measured using a standardised generic questionnaire such as
EQ-5D, Short Form (SF)-36, SF-12 or SF-6 or wound-specific
questionnaires such as the Cardiff wound impact schedule). We
did not include ad hoc measures of quality of life that are unlikely
to be validated and would not be common to multiple trials.
• Wound recurrence: we accepted study author definitions of
wound recurrence unless it was clear that the term had not been
used to describe the return of a wound that was previously
healed.
• Mean pain scores: (including pain at dressing change) were
included only where reported as either a presence or absence of
pain or as a continuous outcome using a validated scale such as a
visual analogue scale (VAS).
• Within-trial cost-effectiveness analysis comparing mean
differences in effects with mean cost differences between the two
arms: data extracted were incremental mean cost per incremental
gain in benefit (incremental cost-effectiveness ratio (ICER)). The
inclusion of this outcome represents a change from the protocol;
see Differences between protocol and review for more details.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases for RCTs:
• the Cochrane Wounds Specialised Register (searched 25
June 2018);
• the Cochrane Central Register of Controlled Trials
(CENTRAL; 2018, Issue 5) in the Cochrane Library (searched
25 June 2018);
• Ovid MEDLINE including In-Process & Other Non-
Indexed Citations (1946 to 25 June 2018);
• Ovid Embase (1974 to 25 June 2018);
• EBSCO CINAHL Plus (1937 to 25 June 2018).
The search strategies for the Cochrane Wounds Specialised Reg-
ister, CENTRAL, Ovid MEDLINE, Ovid Embase and EBSCO
CINAHL Plus can be found in Appendix 1. We combined
the Ovid MEDLINE search with the Cochrane Highly Sensi-
tive Search Strategy for identifying randomised trials in MED-
LINE: sensitivity- and precision-maximising version (2008 re-
vision) (Lefebvre 2011). We combined the Embase search with
the Ovid Embase filter developed by the UK Cochrane Cen-
tre (Lefebvre 2011). We combined the EBSCO CINAHL Plus
searches with the trial filters developed by the Scottish Intercol-
legiate Guidelines Network (SIGN 2017). There were no restric-
tions with respect to language, date of publication or study setting.
We also searched the following clinical trials registries for unpub-
lished and ongoing studies in the area - we searched for trials eval-
uating NPWT and explored these records for those pertaining to
traumatic wounds as defined above:
• ClinicalTrials.gov (www.clinicaltrials.gov) (searched 30 May
2018);
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• WHO International Clinical Trials Registry Platform (
ICTRP) ( www.who.int/ictrp/search/en/) (searched 30 May
2018);
• EU Clinical Trials Register ( www.clinicaltrialsregister.eu/
ctr-search/search) (30 May 2018).
Search strategies for clinical trials registries can be found in
Appendix 1.
Searching other resources
We contacted corresponding study authors and themanufacturers
and distributors of NPWT.We aimed to identify other potentially
eligible trials or ancillary publications by searching the reference
lists of retrieved included trials as well as relevant systematic re-
views, meta-analyses, and health-technology assessment reports.
Data collection and analysis
We carried out data collection and analysis according to methods
stated in the published protocol (Newton 2017), whichwere based
on the Cochrane Handbook for Systematic Reviews of Interventions
(Higgins 2011a).
Selection of studies
Two review authors independently assessed the titles and abstracts
of the citations retrieved by the searches for relevance. After this
initial assessment, we obtained full-text copies of all studies con-
sidered to be potentially relevant. Two review authors indepen-
dently checked the full papers for eligibility; we resolved any dis-
agreements by discussion and, where required, the input of a third
review author. Where required and possible, we contacted study
authors where the eligibility of a study was unclear. We recorded
all reasons for exclusion of studies for which we had obtained full
copies.We completed a PRISMA flowchart to summarise this pro-
cess (Liberati 2009).
Where studies had been reported in multiple publications/reports
we obtained all publications. Whilst the study would be included
only once in the review, we intended to extract data from all reports
to ensure maximal relevant data were obtained.
Data extraction and management
We extracted and summarised details of the eligible studies using
a data extraction sheet. Two review authors extracted data inde-
pendently and resolved disagreements by discussion, drawing on
a third review author where required. Review authors who had
authored included studies did not participate in data extraction or
checking. Where data were missing from reports, we attempted
to contact the study authors to obtain this information. Where
a study with more than two intervention arms was included, we
extracted only data from intervention and control groups that met
the eligibility criteria. In the case of a three-arm trial with two
NPWT groups and a control group, we extracted all data and re-
ported comparisons narratively. Review authorsmade a decision as
to how to analyse data further but ensured that multiple analyses,
which posed a risk of spurious findings, were avoided. Options
included grouping NPWT groups together or the inclusion of
comparisons in different meta-analyses depending on treatments
being evaluated.
We extracted the following data, where possible, by treatment
group for the pre-specified interventions and outcomes in this re-
view. We collected outcome data for relevant time points as de-
scribed in Types of outcomemeasures.Where details were unclear,
we contacted study authors for clarification where possible:
• country of origin;
• type of wound (including whether it was an open fracture
wound);
• unit of randomisation (per participant) - single wound or
multiple wounds on the same participant;
• unit of analysis;
• trial design, for example, parallel, cluster;
• care setting;
• number of participants randomised to each trial arm;
• eligibility criteria and key baseline participant data;
• details of treatment regimen received by each group;
• duration of treatment;
• details of any co-interventions;
• primary and secondary outcome(s) (with definitions);
• outcome data for primary and secondary outcomes (by
group);
• duration of follow-up;
• number of withdrawals (by group);
• publication status of study; and
• source of funding for trial.
Assessment of risk of bias in included studies
Two review authors independently assessed included studies using
the Cochrane tool for assessing risk of bias (Higgins 2011b). This
tool addresses six specific domains: sequence generation, alloca-
tion concealment, blinding, incomplete data, selective outcome
reporting and other issues. In this review we recorded issues with
unit of analysis, for example where a cluster trial had been un-
dertaken but analysed at the individual level in the study report
(Appendix 2). We assessed blinding and completeness of outcome
data for each of the review outcomes separately.We note that, since
wound healing is a subjective outcome, it can be at high risk of
measurement bias when outcome assessment is not blinded. We
presented our assessment of risk of bias using two ’Risk of bias’
summary figures; one is a summary of bias for each item across all
studies, and the second shows a cross-tabulation of each trial by all
of the risk of bias items. We classed studies with an assessment of
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high risk of bias for the randomisation sequence domain and/or
the allocation concealment domain and/or the blinded outcome
assessment domain (for specified outcome) as being at overall high
risk of bias (for specified outcome).
If trials using cluster randomisation become available in future
updates, we will also consider the risk of bias from recruitment
bias, baseline imbalance, loss of clusters, incorrect analysis and
comparabilitywith individually randomised trials (Higgins 2011c)
(Appendix 3).
Measures of treatment effect
For dichotomous outcomes we calculated the risk ratio (RR) with
95% confidence intervals (CI). For continuously distributed out-
come data we used the mean difference (MD) with 95% CIs. If
trials reporting continuous data used different assessment scales,
we would have used the standardised mean difference (SMD) with
95% CIs. We would have only considered mean or median time
to healing without survival analysis as a valid outcome if reports
specified that all wounds had healed (i.e. if the trial authors re-
garded time-to-healing as a continuous measure as there was no
censoring). We intended to report time-to-event data (e.g. time-
to-complete wound healing) as hazard ratios (HR), where pos-
sible in accordance with the methods described in the Cochrane
Handbook for Systematic Reviews of Interventions (Deeks 2011). In
future updates, if studies reporting time-to-event data (e.g. time
to healing) do not report a hazard ratio, then, where feasible, we
plan to estimate this using other reported outcomes, such as the
numbers of events, through the application of available statistical
methods (Parmar 1998).
Unit of analysis issues
Where studies randomised at the participant level and measured
outcomes at the wound level, for example, wound healing, we
treated the participant as the unit of analysis when the number
of wounds assessed appeared equal to the number of participants
(e.g. one wound per person).
Particular unit of analysis issues in wound care trials can occur
when (1) studies randomise at the participant level, use the al-
located treatment on multiple wounds per participant, and then
analyse outcomes per wound, or (2) studies undertake multiple
assessments of an outcome over time per participant. These ap-
proaches were to be treated as cluster trials, alongside more stan-
dard cluster designs, such as delivery of interventions at an organ-
isational level. There was only one study where a participant had
more than onewound and the unit of randomisation differed from
the unit of analysis. As we were unable to quantify the difference
this would have made to the study findings we decided to use the
participants as the unit of analysis.
Where a cluster trial had been conducted and correctly analysed,
we planned to use the generic inverse-variance method in Review
Manager 5 (RevMan 5) (RevMan 2014) to meta-analyse effect
estimates and their standard errors.
We planned to record where a cluster-randomised trial had been
conducted but incorrectly analysed. This was to be recorded as
part of the ’Risk of bias’ assessment. If possible we would have ap-
proximated the correct analyses based on guidance in theCochrane
Handbook for Systematic Reviews of Interventions (Higgins 2011d)
using information on:
• the number of clusters (or groups) randomised to each
intervention group; or the average (mean) size of each cluster;
• the outcome data ignoring the cluster design for the total
number of individuals (for example, number or proportion of
individuals with events, or means and standard deviations);
• and an estimate of the intra-cluster (or intra-class)
correlation coefficient (ICC).
If the study data could not be analysed correctly, we would have
extracted and presented outcome data but not analysed them fur-
ther.
We would have also noted when randomisation had been under-
taken at the wound level; that is a split-site or split-body design.
We planned to assess whether the correct paired analysis had been
undertaken in the study. Again, we planned to record issues in the
’Risk of bias’ section. If an incorrect analysis had been undertaken
we would have approximated a correct analysis if the required data
were available from the study report or the study authors. If this
was not possible we would have extracted and presented the rele-
vant outcome data but not analysed them further.
Dealing with missing data
It is common to have data missing from trial reports. Exclud-
ing participants post-randomisation from the analysis, or ignoring
those participants who are lost to follow-up compromises the ran-
domisation, and potentially introduces bias into the trial. Where
there were missing data that the review authors thought should
have been included in the analyses, we contacted the relevant study
authors to request whether these data were available.
Where an included study reported on wound healing or wound
infection and data were missing, for analysis we assumed that if
randomised participants were not included in an analysis, their
wound did not heal (i.e. they were considered in the denominator
but not the numerator).
For all secondary outcomes we presented available data from the
study reports/study authors and did not impute missing data.
Where measures of variance were missing and calculation was not
possible we contacted study authors.Where thesemeasures of vari-
ation were not available, we excluded the study from any relevant
meta-analyses that were conducted.
Assessment of heterogeneity
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Assessment of heterogeneity can be a complex, multi-faceted pro-
cess. Firstly, we considered clinical and methodological hetero-
geneity: that is, the degree to which the included studies varied
in terms of participant, intervention, outcome and characteris-
tics such as length of follow-up. This assessment of clinical and
methodological heterogeneity was supplemented by information
regarding statistical heterogeneity, assessed using the Chi² test (we
considered a significance level of P ¡ 0.10 to indicate statistically sig-
nificant heterogeneity) in conjunctionwith the I² statistic (Higgins
2003). I² examines the percentage of total variation across RCTs
that is due to heterogeneity rather than chance (Higgins 2003). In
general I² values of 40%, or less, may not be important (Higgins
2003), and values of more than 75%, or more, indicate consider-
able heterogeneity (Deeks 2011). However, these figures are only
a guide and it has been recognised that statistical tests and met-
rics may miss important heterogeneity. Thus, whilst these were as-
sessed, the overall assessment of heterogeneity assessed these mea-
sures in combination with the methodological and clinical assess-
ment of heterogeneity. Where there was evidence of high hetero-
geneity we attempted to explore this further: see Data synthesis
for further information about how we handled potential hetero-
geneity in the data analyses.
Assessment of reporting biases
Reporting biases arise when the dissemination of research findings
is influenced by the nature and direction of results. Publication
bias is one of a number of possible causes of ’small study effects’,
that is, a tendency for estimates of the intervention effect to be
more beneficial in smaller RCTs. Funnel plots allow a visual as-
sessment of whether small study effects may be present in a meta-
analysis. A funnel plot is a simple scatter plot of the intervention
effect estimates from individual RCTs against some measure of
each trial’s size or precision (Sterne 2011). We planned to present
funnel plots for meta-analyses comprising 10 RCTs or more using
RevMan 5 (RevMan 2014).
Data synthesis
We combined details of included studies in a narrative review.Data
are presented separately for open fractures and other open trau-
matic wounds. Within these sub-populations comparisons were
further structured according to type of comparator and then by
outcomes ordered by follow-up period.We considered clinical and
methodological heterogeneity and undertook pooling when stud-
ies appeared appropriately similar in terms of wound type, inter-
vention type, duration of follow-up and outcome type.
We were unable to pre-specify the amount of clinical, method-
ological and statistical heterogeneity in the included studies. Thus,
we used a random effects approach for meta-analysis. Conducting
meta-analysis with a fixed effect model in the presence of even
minor heterogeneity may provide overly narrow confidence in-
tervals. We would only have used a fixed-effect approach when
clinical and methodological heterogeneity was assessed to be min-
imal, and the assumption that a single underlying treatment effect
was being estimated held. Chi-squared and I-squared were used
to quantify heterogeneity but were not used to guide choice of
model for meta-analysis. We would have exercised caution when
meta-analysed data were at risk of small study effects because use
of a random effects model may be unsuitable here. In this case, or
where there were other reasons to question the selection of a fixed
effect or random effects model, we planned to assess the impact of
the approach using sensitivity analyses to compare results from al-
ternate models, but this was not implemented (Thompson 1999).
We presented data using forest plots where possible. For dichoto-
mous outcomes we presented the summary estimate as a risk ratio
(RR) with 95% CI. Where continuous outcomes were measured,
we presented amean difference (MD)with 95%CI; we planned to
pool standardised mean difference (SMD) estimates where studies
measured the same outcome using differentmethods. For time-to-
event data, we planned to plot (and, if appropriate, pool) estimates
of hazard ratios and 95% CIs as presented in the study reports
using the generic inverse-variance method in RevMan 5 (RevMan
2014). In future updates, where time-to-healing is analysed as a
continuous measure but it is not clear if all wounds healed, we will
document use of the outcome in the study but will not summarise
data or use them in any meta-analysis.
We obtained pooled estimates of treatment effect from the avail-
able data using RevMan 5 software (RevMan 2014).
’Summary of findings’ tables
We presented the main results of the review in ’Summary of find-
ings’ tables where data were available. These tables present key in-
formation concerning the certainty of the evidence, themagnitude
of the effects of the interventions examined, and the sum of the
available data for the main outcomes (Schünemann 2011a). The
’Summary of findings’ tables also include an overall grading of the
evidence related to each of the main outcomes using the GRADE
approach, which defines the certainty of a body of evidence as the
extent to which one can be confident that an estimate of effect or
association is close to the true quantity of specific interest. The
certainty of a body of evidence involves consideration of within-
trial risk of bias (methodological quality), directness of evidence,
heterogeneity, precision of effect estimates and risk of publication
bias (Schünemann 2011b). We planned to present the following
outcomes in the ’Summary of findings’ tables:
• time to complete wound healing, where analysed using
appropriate survival analysis methods
• proportion of wounds completely healed during the trial
period (with or without surgery)
• wound infection
• adverse events
• time to closure or coverage surgery
• mean pain scores.
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Subgroup analysis and investigation of heterogeneity
We had previously suggested that we would conduct subgroup
analysis on primary outcomes based on type of traumatic wound.
However, following the protocol stage of the review we revised our
plan to present the results of the review by two distinct subpopula-
tions and did not conduct further subgroup analysis within these.
We did not conduct any further pre-specified subgroup analysis
based on the categories below due homogeneity in the data or lack
of data, or both:
• grade of wound injury
• contamination level of wounds.
Sensitivity analysis
We planned to perform sensitivity analyses to explore the effect
of the following, but this was not possible due to lack of available
data:
• removal of studies classed at high risk of bias for any
domain.
We also conducted a post-hoc sensitivity analysis exploring the
impact of using alternate wound infection data from Costa 2017.
R E S U L T S
Description of studies
Results of the search
We present the results of the search in the PRISMA diagram (
Figure 1). The literature search found 175 records after duplicates
were removed. From the initial screening we removed 142 records
and sought 33 full-text articles for further scrutiny. Of the 33
articles that we scrutinised, we included seven studies (reported in
eight articles) and excluded 20 studies (reported in 25 articles).We
did not identify any ongoing studies and there are none awaiting
classification.
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Figure 1. Study flow diagram
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Study characteristics are detailed (Characteristics of included
studies; Characteristics of excluded studies) and summarised be-
low. We contacted all trial authors for additional information and
missing data; any responses are noted in relevant tables.
Included studies
Study design and setting
All studies were two-arm, parallel-group RCTs except Chen 2016,
which was a three-arm trial. One study provided care in a ra-
bies clinic ( Chen 2016) and two in hospital orthopaedic wards
( Ondieki 2012; Stannard 2009). Studies were conducted in dif-
ferent countries as follows: China ( Chen 2016), India ( Virani
2016), Iran ( Arti 2016),Kenya ( Ondieki 2012), Turkey ( Keskin
2008), the UK (Costa 2017) and the USA ( Stannard 2009). Two
studies reported their funding source: Stannard 2009 received a
grant fromamanufacturer ofwoundhealing technology andCosta
2017 was funded by the UK National Institute for Health Re-
search.
Participants
Sample size ranged between 40 and 586 participants.
• Four trials included only participants with open fractures
where NPWT was used on open wounds ( Arti 2016; Costa
2017; Stannard 2009; Virani 2016). In Arti 2016 participants
had to be aged between 15 and 55 years, in Costa 2017 16 years
or older and in Stannard 2009 and Virani 2016 over 18 years.
The severity of open fractures (based on the Gustilo-Anderson
classification) varied but largely included the more severe
injuries, which are those that cannot be closed after initial
surgical debridement. Arti 2016 included participants with a
grade IIIB open fracture; Costa 2017 those with a grade II or III
open fracture; Stannard 2009 and Virani 2016 included heavily
contaminated grade II and IIIA open fractures, grade IIIA
injuries with very severe soft tissue damage and all IIIB or IIIC
open fractures.
• Three trials included participants with other types of open
traumatic wounds (Chen 2016; Keskin 2008; Ondieki 2012).
Ondieki 2012 included trauma wounds with a contamination
level of dirty, involving soft tissue loss on the lower limb, Keskin
2008 included people with general traumatic wounds with no
further information and Chen 2016 included people with severe
dog bites to the limbs. Chen 2016 notes that 13% of participants
suffered open fractures, with some participants also having finger
amputation. Participants needed to be over 12 years in Ondieki
2012 and over 18 years in Chen 2016 and Keskin 2008.
Interventions
Open fracture trials
Arti 2016; Stannard 2009 and Virani 2016 assessed NPWT use
at 125 mmHg. In Costa 2017, the amount of pressure applied
was at the discretion of the clinician, but 125 mmHg was the
predominant setting.
TheNPWTdressingusedwas noted as: solid foamor gauze (Virani
2016) ’open-cell’ solid foam or gauze (Costa 2017), sponge foam
(Arti 2016), and ’VAC dressing’, which the review authors believe
to be GranuFOAM (Stannard 2009). The control arm in the stud-
ies received conventional wound care consisting of cleaning and
dressing (in the absence of NPWT), which we refer to in this re-
view as ’standard care’. Dressings in the control groups varied be-
tween studies being described as conventional in Arti 2016; saline
dressings in Stannard 2009 and not described in Virani 2016.
Costa 2017 described use of a standard dressing comprising a non-
adhesive layer applied directly to the wound, covered by a sealed
dressing or bandage: the study notes that the exact details of the
materials used were left to the discretion of the treating surgeon
as per UK routine care.
All studies used NPWT following surgical debridement until
wounds were ready for coverage or closure surgery, after which
they followed up to assess subsequent outcomes, such as wound
infection and healing. All studies periodically carried out further
debridement and all had regimes using antibiotic prophylaxis.
• Arti 2016: used NPWT on debrided open wounds for 10
to 14 days with the aim of reducing wound size and promoting
granulation to allow either change to a conventional dressing or
further surgery for skin grafting or flap closure.
• Costa 2017: following UK guidelines the aim was to use
NPWT on debrided, open wounds until a second operation
between 48 and 72 hours after the first. The second surgery
involved further debridement and wound closure or soft tissue
reconstruction where possible. Where further use of dressings for
open wounds were required this followed the allocated treatment
until definitive closure/cover of the wound.
• Stannard 2009: after initial debridement participants were
allocated to trial treatment with subsequent surgeries within 36
to 72 hours until the wound was granulated and ready for
coverage or closure surgery.
• Virani 2016: used the trial treatments until the wound was
granulated and the participant was able to undergo coverage or
closure surgery. Participants had serial irrigation and
debridements during treatment.
Other open traumatic wounds trials
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All studies (Chen2016; Keskin 2008;Ondieki 2012) usedNPWT
at 125 mmHg and 75 mmHg (Chen 2016). The NPWT dress-
ing used was noted as: a combined with polyvinyl alcohol shrink
formaldehyde bubble dressing ( Chen 2016); a polyurethane foam
( Keskin 2008) and a sterile foam manufactured by Bobamil and
gauze ( Ondieki 2012). The control arm in the studies received
conventional wound care consisting of cleaning and dressing ( in
the absence of NPWT), which we refer to in this review as ’stan-
dard care’. Dressings in the control groups varied between studies
being described as ”sterilised’ ( Chen 2016) or gauze ( Keskin
2008; Ondieki 2012).
• Chen 2016: used NPWT on clean and debrided wounds
and following surgery to repair damaged bone, organs and
muscle. They removed NPWT after four to five days following
initial surgery and followed the wound to healing.
• Ondieki 2012: used NPWT until the wound achieved
100% granulation and was ready for closure or coverage surgery.
• Keskin 2008: did not present any information on the
timing and treatment aims of NPWT use.
Outcomes
None of the included studies reported the number of wounds
closed with surgery or wound recurrence. Duration of follow-up
rangedbetween10days ( Keskin 2008) and67months ( Stannard
2009).
The studies reported the following outcomes:
Open fracture wound trials
• Number of wounds healed: Costa 2017
• Wound infection: Arti 2016; Costa 2017; Stannard 2009;
Virani 2016. Costa 2017 reported unblinded data for superficial
and deep wounds at 30 days and for persistent and deep wound
infection diagnosed after 30 days and before 12 months. They
also reported the blinded assessment of wound infection (per
participant at six weeks) (see Table 1). We used the blinded, six-
week wound infection data and explored use of unblinded, 30-
day wound infection outcome data (superficial and deep
infection data at 30 days combined) in a post hoc sensitivity
analysis. Additional data are presented in Table 1. Costa 2017
was the only study to present clearly blinded data for this
outcome.
• Adverse events: Costa 2017
• Time to surgery: Stannard 2009; Virani 2016
• Health-related quality of life: Stannard 2009; Costa 2017
• Cost effectiveness: Costa 2017
Other open traumatic wounds trials
• Time to wound healing: Chen 2016
• Wound infection: Chen 2016; Ondieki 2012
• Time to closure or coverage surgery (time to full
granulation): Ondieki 2012
• Pain: Ondieki 2012
• Keskin 2008 did not report any outcomes relevant to the
review.
Excluded studies
We excluded 20 studies for including an ineligible patient popula-
tion (Braakenburg 2006; Dorafshar 2012; Moisidis 2004; Mouës
2004; Mouës 2005; Mouës 2007; Mouës 2008; Rahmanian-
Schwarz 2012; Stannard 2006; Stannard 2012), having an in-
eligible study design (Rovee 2004; Brown 2012; Fleischmann
1993; Fleischmann 1995; Lesiak 2013;MAS 2006; Ubbink 2008;
Vikatmaa 2008) and using an ineligible intervention (Colom
2006; Jeschke 2004).
Risk of bias in included studies
Details of the risk of bias in the included studies are presented
in the ’Risk of bias’ tables (Included studies) and summarised for
each study in Figure 2 and overall in Figure 3. Overall none of the
studies were at low risk of bias for all domains. All studies were at
high risk of performance bias, which is common in device trials
where it is difficult to blind health professionals and participants
to treatments applied to wounds.
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Figure 2. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
study
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Figure 3. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included studies
Two studies had no additional domains with a high risk of bias
(Costa 2017; Virani 2016). The remaining five studies were at
high risk of bias for two domains; the additional domains with
high risk of bias varied.
Allocation
Randomisation was adequately undertaken using random number
tables, computer, a random number generator and algorithm in
five studies ( Chen 2016; Costa 2017 Ondieki 2012; Stannard
2009; Virani 2016), but was not clearly described in two studies
(Arti 2016; Keskin 2008). We classed allocation concealment as
unclear in all studies except Costa 2017, where further details from
the study authors confirmed that adequate allocation concealment
had been conducted.
Blinding
Blinding to delivering or receiving interventions that are clearly
different is challenging and often not achievable, therefore we as-
sessed all studies as high risk of performance bias. Blind outcome
assessment was notmentioned, therefore all studies were at unclear
risk of detection bias except Ondieki 2012, which we assessed as
being at high risk of detection bias for stating that the evaluation
of outcomes such as pain may have been biased; and Costa 2017,
which we assessed as being at low risk of detection bias for using
blind outcome assessors for wound healing and wound infection
outcomes.
Incomplete outcome data
We assessed four studies as being at low risk of bias given that
there was minimal (Ondieki 2012; Stannard 2009; Virani 2016)
or no (Arti 2016) loss to follow-up/exclusion. One study recruited
additional participants to make up for attrition (Keskin 2008) (see
other potential sources of bias). Chen 2016 was at high risk of
attrition bias due to an imbalance in attrition across groups. Costa
2017 randomised 625 participants in an emergency setting where
potentially eligible patients often went immediately into theatre
and/or were unconscious or had reduced levels of consciousness
- a number of randomised participants could only be assessed
and consented post randomisation, leading to inclusion of 460
participants in the final trial follow-up and results. We classed this
study as being at unclear risk of bias.
Selective reporting
We assessed Arti 2016 as being at high risk of reporting bias for not
reporting a proposed outcome and reporting a surrogate outcome
instead. We also classed Stannard 2009 as being at high risk of
bias, having measured but failed to report the 12-month and final
follow-up data for the health-related quality of life outcome. Trial
registration was not available for any included study except Costa
2017, however, from data included in the methods of papers, we
judged that all measured outcomes appeared to have been reported
in Keskin 2008 and Ondieki 2012; we judged the three studies to
18Negative pressure wound therapy for open traumatic wounds (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
be at low risk of bias. It was unclear whether all measured outcomes
were reported in Virani 2016. Chen 2016 reported an average of
4.6 wounds even though the unit of analysis and randomisation
appear to be the participants. We assessed all three studies as being
at unclear risk of bias.
Other potential sources of bias
We assessed Keskin 2008 as being at high risk of other bias because
of a difference in frequency of change of wound dressings, which
may have resulted in bias. The assignment of additional partici-
pants to study groups to replace those lost to follow-up may also
not have been done at random.
Effects of interventions
See: Summary of findings for themain comparisonNPWT125
mmHg compared with standard care in open fracture wounds;
Summary of findings 2 NPWT 125 mmHg compared with
standard care in other open traumatic wounds; Summary of
findings 3 NPWT 75 mmHg compared with standard care in
other open traumatic wounds; Summary of findings 4 NPWT
125 mmHg compared with NPWT 75 mmHg in other open
traumatic wounds
All extracted data are reported here: Table 1.
Negative pressure wound therapy versus standard
care in open fracture wounds
Comparison 1. Negative pressure wound therapy 125
mmHg versus standard care (4 studies; 701 participants)
Four studies with 701 participants assessed this comparison (Arti
2016; Costa 2017; Stannard 2009; Virani 2016).Whilst the mag-
nitude of applied pressure was pragmatic in the Costa 2017 study,
the majority of participants received NPWT at 125 mmHg, thus
we have included it in this comparison.
Summary of findings for the main comparison
Primary outcomes
Complete wound healing
Only Costa 2017 reported the number of healed wounds, this was
at sixweeks following randomisation.Therewas no clear difference
in the number of participants with a healed wound between the
NPWT and the standard care groups (RR 1.01, 95% CI 0.81 to
1.27; 460 participants); moderate-certainty evidence downgraded
once for imprecision (Analysis 1.1).
Wound infection
Duration of follow-up for wound infection was not clear in all
studies but was largely around 30 days. It is uncertain whether
NPWT 125 mmHg reduces the risk of wound infection in open
fracture wounds compared with standard care over this follow-up
period (RR 0.48, 95%CI 0.20 to 1.13; 4 studies (Arti 2016; Costa
2017; Stannard 2009; Virani 2016); 596 participants; I2 = 56%);
very low-certainty evidence, downgraded due to serious risk of
bias, serious inconsistency and serious imprecision (Analysis 1.2).
In a post-hoc sensitivity analysiswe re-analysed these data using the
unblinded, combined deep and superficial surgical site infection
data at 30days’ follow-up fromCosta 2017.Therewas little change
to findings (RR 0.49, 95% CI 0.19 to 1.27; 4 studies (Arti 2016;
Costa 2017; Stannard 2009; Virani 2016); 701 participants (more
data from Costa 2017 included in this analysis); I2 = 66%) (
Analysis 1.3).
Adverse events
Costa 2017 presented data onpost-operative complications related
to the relevant open fracture 12 months following randomisation.
These are presented here as further surgery and other wound-
related complications in the trial. There were 111 further wound-
related surgical events in the standard care arm and 95 in the
NPWT arm. There were 43 other post-operative complications in
the standard care arm and 39 in the NPWT arm. No difference
was reported as statistically significant in the trial report. We have
not re-analysed the data here due to their clustered nature (event
clustered by person).
Secondary outcomes
Time to closure or coverage surgery
Time to closure or coverage surgery was reported in two studies
(Stannard 2009; Virani 2016) analysing 151 participants. Mean
time to further surgery ranged between 4 to 8.3 days with NPWT
and 3.2 to 9.8 days with standard care, however, we were unable to
analyse the results as the studies did not reportmeasures of variance
or we were unable to obtain them. It is uncertain whether NPWT
125 mmHg reduces the time to closure or coverage surgery for
open fracture wounds because the certainty of the evidence is very
low. The evidence was downgraded for serious risk of bias and very
serious imprecision.
Health-related quality of life
This evidence is from two studies (518 participants) (Costa 2017;
Stannard 2009) that measured health-related quality of life at 3
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months, 6 months, 9 months and 12 months. Stannard 2009
used the short form-36 (SF-36), reporting the physical component
score (PCS score) in participants who were infected (a subgroup of
the overall population; we have presented data in Table 1). Costa
2017 used the SF-12 and EQ-5D utility and also assessed data
at 12 months. As noted in the methods we reported the latest
time point here. There is probably no clear difference in the EQ-
5D utility score at 12 months between NPWT and standard care
(MD -0.01, 95% CI -0.08 to 0.06; 364 participants); moderate-
certainty evidence downgraded once for imprecision. There is no
clear difference in SF-12 PCS score (MD -0.50, 95% CI -4.08 to
3.08; 329 participants); low-certainty evidence downgraded twice
for imprecision (Analysis 1.4).
Cost effectiveness
Costa 2017 reported that it was unlikely that NPWT was a cost-
effective treatment. The mean total cost of resource use was GBP
678 (95%CIGBP -1082 to 2438)more in theNPWTgroup than
the control group. Incremental mean quality-adjusted life years
(QALYs) were very slightly higher in the NPWT group: 0.002 (-
0.0054 to 0.059): the incremental cost-effectiveness ratio (ICER)
was GBP 267,910. To further explore uncertainty in findings, the
authors assessed the probability of NPWT being cost effective for
open fracturewounds at cost-per-QALY thresholds ofGBP15,000
to GBP 30,000. The probability of NPWT being cost effective
at these threshold was never higher than 27%; moderate-certainty
evidence downgraded once for serious imprecision.
Other outcomes
None of the included studies reported proportion of wounds
closed with coverage or closure surgery and wound recurrence.
Negative pressure wound therapy versus standard
care in other open traumatic wounds
Comparison 2. Negative pressure wound therapy 125
mmHg versus standard care (2 studies; 509 participants)
Primary outcomes
Complete wound healing
Chen 2016 reported time to wound healing but this was stratified
by infection status and presented as mean data when it was not
clear that all wounds had healed, in which case the mean is not an
appropriate summary measure. We have presented outcome data
in Table 1 but have not analysed them further.
Wound infection
Two studies with 509 participants contributed data to this com-
parison (Chen 2016; Ondieki 2012). The duration of follow-up
for outcome assessment was not clear. Both studies had a total
follow-up duration of six months. There is no clear difference be-
tween NPWT and standard care-treated wounds in the risk of
wound infection (RR 0.61, 95% CI 0.31 to 1.18; 509 partici-
pants; 2 studies; I2 = 0%); low-certainty evidence downgraded due
to serious risk of bias and serious imprecision (Analysis 2.1).
Adverse events
Not reported for this comparison.
Secondary outcomes
Pain
One study with 51 participants with soft tissue trauma wounds
measured pain using the numeric rating scale ranging from 0 (no
pain) to 10 (worst possible pain) (Ondieki 2012). There is no clear,
clinically meaningful difference in pain score between the inter-
vention groups from current evidence (MD 0.30, 95% CI -0.22
to 0.82; 51 participants; 1 study); low-certainty evidence down-
graded for serious risk of bias and serious imprecision (Analysis
2.2).
Comparison 3. Negative pressure wound therapy 75 mmHg
versus standard care (1 trial; 463 participants)
One trial assessed this comparison (Chen 2016). This was a three-
arm study involving people with soft tissue trauma, and 463 of
the 586 participants were included in this comparison.
Primary outcomes
Complete wound healing
Chen 2016 reported time to wound healing but this was stratified
by infection status and presented as mean data when it was not
clear that all wounds had healed.We have presented outcome data
Table 1 but not analysed them further.
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Wound infection
The duration of follow-up was unclear. It is uncertain if there
is a difference in risk of wound infection between NPWT 75
mmHg and standard care (RR 0.44, 95% CI 0.17 to 1.10; 463
participants; 1 study). The evidence is very low certainty and we
downgraded it for serious risk of bias and very serious imprecision
(Analysis 3.1).
Adverse events
Not reported for this comparison.
Secondary outcomes
Not reported for this comparison.
Different pressures of negative pressure wound
therapy in other open traumatic wounds
Comparison 4. Negative pressure wound therapy 125 mmHg
versus negative pressure wound therapy 75 mmHg (1 trial;
251 participants contributing data to this comparison)
One trial assessed this comparison (Chen 2016). This was a three-
arm study involving people with soft tissue trauma, and 251 of
the 586 participants were included in this comparison.
Primary outcomes
Complete wound healing
Not reported for this comparison.
Wound infection
The duration of follow-up was unclear. It is uncertain if there is a
difference in risk of wound infection between NPWT 75 mmHg
and 125mmHg (RR 1.04, 95%CI 0.31 to 3.51; 251 participants;
1 study) because the certainty of the evidence is very low. We
downgraded the evidence for serious risk of bias and very serious
imprecision (Analysis 4.1).
Adverse events
Not reported for this comparison.
Secondary outcomes
Not reported for this comparison.
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A D D I T I O N A L S U M M A R Y O F F I N D I N G S [Explanation]
NPWT 125 mmHg compared with standard care in other open traumatic wounds
Patient or population: other open traumatic wounds
Setting: rabies clinic and orthopaedic ward
Intervention: NPWT 125 mmHg
Comparison: standard care (other dressings)
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with standard care Risk with NPWT 125
mmHg
Complete wound heal-
ing
Not est imable Not est imable Not est imable Not est imable Not est imable One study reported t ime
to complete healing but
this was strat if ied by in-
fect ion status and pre-
sented as mean data
when it was not clear
that all wounds had
healed. Data were not
analysed further
Wound infection
Follow-up: not clear
103 per 1000 63 per 1000 (32 to 121) RR 0.61 (0.31 to 1.18) 509 (2 studies) ⊕⊕©©
Low1
There is no clear dif -
ference in NPWT 125
mmHg compared with
standard care on risk
of wound infect ion f rom
current evidence
Adverse events Not est imable Not est imable Not est imable Not est imable Not est imable -
Time to closure or cov-
erage surgery
Not est imable Not est imable Not est imable Not est imable Not est imable -
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Pain
NRS f rom 0 (no pain)
to 10 (worst possible
pain)
Follow-up: 6 to 18 days
The mean pain score in
the control group was
4.4 units
The mean pain score in
the intervent ion group
was 0.3 units higher
(0.22 lower to 0.82
higher)
- 51
(1 study)
⊕⊕©©
Low2
There is no clear, clini-
cally meaningful dif f er-
ence, in pain score be-
tween the intervent ion
groups f rom current ev-
idence
*The risk in the intervention group (and its 95% conf idence interval) is based on the median risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; NRS: numeric rat ing scale; RR: risk rat io
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded two levels: once for serious risk of bias (no blind outcome assessment and loss to follow-up) and once due to
imprecision due to small sample size.
2Downgraded two levels: once for serious risk of bias and once for serious imprecision.
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NPWT 75 mmHg compared with standard care in other open traumatic wounds
Patient or population: other open traumatic wounds
Setting: rabies clinic
Intervention: NPWT 75 mmHg
Comparison: standard care
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with standard care Risk with NPWT 75
mmHg
Complete wound heal-
ing
Not est imable Not est imable Not est imable Not est imable Not est imable -
Wound infection
Follow-up: unclear
90 per 1000 39 per 1000
(15 to 99)
RR 0.44
(0.17 to 1.10)
463
(1 study)
⊕©©©
Very low1
It is uncertain whether
there are dif ferences in
incidence of infect ion
between the interven-
t ion groups
Adverse events Not est imable Not est imable Not est imable Not est imable Not est imable -
Time to closure or cov-
erage surgery
Not est imable Not est imable Not est imable Not est imable Not est imable -
Pain Not est imable Not est imable Not est imable Not est imable Not est imable -
*The risk in the intervention group (and its 95% conf idence interval) is based on the median risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; RR: risk rat io
2
4
N
e
g
a
tiv
e
p
re
ssu
re
w
o
u
n
d
th
e
ra
p
y
fo
r
o
p
e
n
tra
u
m
a
tic
w
o
u
n
d
s
(R
e
v
ie
w
)
C
o
p
y
rig
h
t
©
2
0
1
8
T
h
e
C
o
c
h
ra
n
e
C
o
lla
b
o
ra
tio
n
.
P
u
b
lish
e
d
b
y
Jo
h
n
W
ile
y
&
S
o
n
s,
L
td
.
GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded three levels: risk of bias (no blind outcome assessment); very serious imprecision due to small sample size and
wide conf idence interval.
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NPWT 125 mmHg compared with NPWT 75 mmHg in other open traumatic wounds
Patient or population: other open traumatic wounds
Setting: rabies clinic
Intervention: NPWT 125 mmHg
Comparison: NPWT 75 mmHg
Outcomes Anticipated absolute effects∗ (95% CI) Relative effect
(95% CI)
of participants
(studies)
Certainty of the evi-
dence
(GRADE)
Comments
Risk with NPWT 75
mmHg
Risk with NPWT 125
mmHg
Complete wound heal-
ing
Not est imable Not est imable Not est imable Not est imable Not est imable -
Wound infection
Follow-up: unclear
39 per 1000 41 per 1000
(12 to 137)
RR 1.04
(0.31 to 3.51)
251
(1 study)
⊕©©©
Very low1
It is uncertain whether
there are dif ferences
in wound infect ion be-
tween the intervent ion
groups
Adverse events Not est imable Not est imable Not est imable Not est imable Not est imable -
Time to closure or cov-
erage surgery
Not est imable Not est imable Not est imable Not est imable Not est imable -
Pain Not est imable Not est imable Not est imable Not est imable Not est imable -
*The risk in the intervention group (and its 95% conf idence interval) is based on the median risk in the comparison group and the relative effect of the intervent ion (and its
95%CI).
CI: conf idence interval; RR: risk rat io
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GRADE Working Group grades of evidence
High certainty: we are very conf ident that the true ef fect lies close to that of the est imate of the ef fect
Moderate certainty: we are moderately conf ident in the ef fect est imate: the true ef fect is likely to be close to the est imate of the ef fect, but there is a possibility that it is
substant ially dif f erent
Low certainty: our conf idence in the ef fect est imate is lim ited: the true ef fect may be substant ially dif f erent f rom the est imate of the ef fect
Very low certainty: we have very lit t le conf idence in the ef fect est imate: the true ef fect is likely to be substant ially dif f erent f rom the est imate of ef fect
1Downgraded three levels: risk of bias (no blind outcome assessment); very serious imprecision due to small sample size and
wide 95% conf idence intervals.
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D I S C U S S I O N
Summary of findings for the main comparison; Summary of
findings 2; Summary of findings 3; Summary of findings 4
Summary of main results
We included seven studies with 1381 participants in the review.
The included studies either comparedNPWTat 125mmHgor 75
mmHg with standard care or NPWT at 125 mmHg with NPWT
at 75mmHg. Four studies enrolled participants with open fracture
wounds.
• There is no clear difference in wound healing between
NPWT 125 mmHg and standard care in open fracture wounds
at six weeks’ follow-up. This is based on moderate-certainty
evidence (1 study, 460 participants, undertaken in the UK).
• It is uncertain whether NPWT 125 mmHg reduces the risk
of wound infection compared with standard care in open
fracture wounds. Very low-certainty evidence (4 studies, 596
participants, varying locations).
• From the EQ-5D utility and SF-12 scores assessed, there is
no clear difference in scores for health-related quality of life
between study groups in open fracture wounds; moderate- and
low-certainty evidence (1 study, 364 and 329 participants
respectively).
• There is moderate-certainty evidence that NPWT 125
mmHg is not a cost-effective treatment for open fractures in the
UK.
• Data on the effectiveness of NPWT for the treatment of
other open traumatic wounds are uncertain and we cannot draw
any conclusions.
Overall completeness and applicability of
evidence
The included studies recruited adults and children with trau-
matic wounds involving open fractures and other open traumatic
wounds. The included studies compared NPWT with standard
care and also compared different NPWT applied at different pres-
sures. Only one study reported complete wound healing and ad-
verse events.Wound infection, which is a key issue in these wounds
was the most commonly reported outcome. Wound recurrence
was also not addressed. Apart from wound infection, the other
outcomes were mostly reported in single studies.
The included studies took place in a range of settings and coun-
tries, including low- to middle-income countries. A recent and
rigorous, publicly-funded study from the UK presented impor-
tant cost-effectiveness information but it is not clear how trans-
ferable these data might be to other countries. The use of NPWT
for the treatment of open fracture wounds was similar in that the
treatment was used on the most serious wounds that could not
be easily covered or closed during initial surgery. The treatment
aim in most open fracture studies was to close the wounds in the
near future, which seems to reflect common practice in this area.
Beyond this, treatment protocol varied across studies in terms of
frequency of dressing change and dressing type, however, these
variations are common in clinical practice. We grouped the re-
maining treatments under other open traumatic wounds, which
we acknowledge is a broad grouping. In this iteration of the re-
view, this group contained only three studies, of which only two
reported data relevant to the review. The types of wounds were
quite different, and one study in particular (Chen 2016) included
people with severe dog bites, which led to a range of injuries in-
cluding partial loss of digits and also some open fractures. The
generalisability from such a grouping is unclear and the evidence
will need to be considered alongside the results of further studies
when these become available.
Quality of the evidence
All the studies were at high risk of bias due to the risk of perfor-
mance bias but this is common in device trials and it is blinded
outcome assessment that is key. We therefore did not downgrade
solely for high risk of performance bias because this was considered
inherent in the nature of the comparisons. Only one study, Costa
2017, clearly stated that it conducted blinded outcome assessment
of wound healing and also wound infection. The blinded assess-
ment process used wound photographs, which the study authors
noted might have been an imperfect method for the assessment of
wound infection in particular. For these reasons we also assessed
the alternative 30-day infection data from this study, and no dif-
ferences in outcome data were reported.
The certainty of evidence was often low or very low. This was due
to the risk of bias, small sample size and wide confidence intervals
that included both an effect and no effect or even a harm of the
intervention.
We were only able to pool data for the wound infection outcome.
Results were uncertain, with studies being imprecise, and there
was heterogeneity between studies in terms of whether confidence
intervals suggested the potential for the true population effect to
be one of harm rather than benefit. The reasons for this are not
clear but the issues of risk of bias and imprecision have led to an
overall assessment of very low-certainty evidence. There was no
indirectness as the studies addressed the population, intervention
and outcome that we set out to address in our protocol. Due to the
paucity of data we were unable to assess the studies for publication
bias.
Potential biases in the review process
In one of the included studies (Ondieki 2012) the unit of ran-
domisation (25 versus 25 participants) differed from the unit of
analysis (25 versus 26 wounds). In that study, one participant ap-
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peared to have multiple wounds, however, we analysed the results
on participant level on the assumption that this would make little
difference to the findings. We made a post hoc decision to include
wound infection as a primary outcome. Changing the outcomes
of a review is often a potential source of bias. However, wound
infection is a clinically important outcome and the fact that it was
not included in the protocol represented an oversight on our part.
The inclusion of this outcome in the review was not driven by the
data available in the included studies. We also made a post hoc
decision to include cost effectiveness as a secondary outcome, in
view of the importance of this in determining the implementation
of relatively high-cost interventions such as NPWT.
Agreements and disagreements with other
studies or reviews
There are no reviews on NPWT for traumatic wounds. Existing
Cochrane Reviews address NPWT for partial thickness burns, sur-
gical wounds, ulcers, and foot wounds in people with diabetes
mellitus. Only two of these reviews reported outcomes relevant to
this review. Both reviews found insufficient evidence to determine
whetherNPWT reduces pain (Dumville 2015a) andwound infec-
tion (Dumville 2015b). We are uncertain about whether NPWT
reduces pain and, on the other hand, found low-certainty evidence
that NPWT may slightly reduce wound infection in traumatic
wounds. However, we note that the participants in the two reviews
are different from the population of interest in our review.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There ismoderate-certainty evidence that negative pressurewound
therapy (NPWT) probably leads to no clear difference in the num-
ber of wounds healed in open fracture wounds when compared
with standard wound care (in the UK context) and is probably not
a cost-effective treatment in the UK. There is insufficient evidence
to determine the effect of NPWT at 125 mmHg on wound infec-
tion, time to coverage or closure surgery, health-related quality of
life and pain in open fracture wounds. There are limited data on
other open traumatic wounds.
Implications for research
There is moderate evidence from one robust study that NPWT in
people with open fractures is probably not cost effective. Evidence
for other outcomes considered in this review are less clear and fur-
ther research is likely warranted, however the clinical and research
community need to consider the research priorities in this het-
erogeneous population. The presence of a robust trial of NPWT
in open fractures may lessen the prioritisation of a repeat trial for
this type of traumatic wound where other uncertainties with less
evidence become key. This might not be the case for other types of
traumatic wounds - depending on how generalisable the clinical
community deems these data. Any new trials should aim to report
on wound healing, infection, adverse events, pain, wound recur-
rence and health- related quality of life. Wound healing should
primarily be investigated as a time-to-event outcome and partici-
pants should be followed up for a sufficient period of time. Trials
should be designed in such a way as to minimise the potential
risks of bias that impacted the studies identified in this review, and
should follow internationally recognised reporting principles.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Arti 2016
Methods 2-arm RCT
Conducted in Iran
Follow-up: 1 month
Participants 90 participants with open fractures
Inclusion criteria: aged 15-55 years; open fracture wound type IIIB based on G/A
classification, and accessible clean wound after debridement
Exclusion criteria: type I, II or IIIA and IIICbased onG/A classification; need of vascular
repair or reconstruction; presence of multiple fractures in extremities; malnutrition;
systemic disease; dermatological disease like psoriasis; taking immunosuppressive drugs;
existence of old fracture or implant in the fractured extremity and previous osteomyelitis
Interventions Group A (n = 45): conventional wound dressing; changed twice a day. No further details
Group B (n = 45): NPWT VAC. The dressings were changed usually every 48 hand
NPWT continued for 10-14 days. Pressure was maintained at 125 mmHg continuously
or intermittently 5min on 2min off. Therapywas stoppedwhen an adequate granulation
base was achieved allowing for change to conventional dressing, split-thickness skin graft,
or flap closure
Co-intervention: open fracture in both wounds underwent debridement before treat-
ment
Outcomes Primary review outcomes: wound infection (defined as purulent discharge from the
wound site or positive culture of the wound)
Secondary review outcomes: none
Notes Funding source not noted but study authors declare no conflicts of interest, the vice-
chancellor for research of Ahwaz
Jundishapur University of Medical Sciences is thanked for support. Research noted as
being “derived from a speciality thesis” of one of the study authors
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “It is a prospective randomised
clinical trial study by simple convenience
sampling conducted”
“Then patients were matched for age, sex
and type of open fracture andwere assigned
to either one of two groups based on ran-
dom table numbers”
Comment: a random number table used.
Possible robust randomisation but process
not clear from paper - classed as unclear
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Arti 2016 (Continued)
Allocation concealment (selection bias) Unclear risk Quote: See above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: no quote
Comment: no mention of blinding but
would not be possible to blind health pro-
fessionals to the different treatments so
without further detail considered high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: no quote
Comment: no mention of blinding in the
paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: no quote
Comment: no evidence of loss to follow-
up or missing data
Selective reporting (reporting bias) High risk Quote: “Wound healing duration, pres-
ence of infection”
Comment: wound surface reduction was
reported rather than wound healing dura-
tion
Other bias Unclear risk Quote: no quote
Comment: none noted but reporting in-
sufficient to be certain
Chen 2016
Methods 3-arm RCT; conducted in Rabies Prophylaxis and Immunity Clinic of Beijing, China
Follow-up: unclear, however, study duration was 6 months
Participants 586 participants with dog bites to their limbs (6 participants receiving standard care
were lost to follow-up and excluded from the analysis). Participants had an average of 4.
6 wounds
Inclusion criteria: aged ¿ 18 years with lacerated limb wounds demanding surgical
treatment (lacerations with lengths of ≥ 5 cm, multiple penetrating lacerations of soft
tissues, or lacerations accompanied by damage to ≥ 1 of the following: muscles, ten-
dons, ligaments, nerves, articular capsules, fractures, important blood vessels, acra [sic]
amputation)
Exclusion criteria: puncture wounds (¡ 2 mm); medium or small lacerations (¡ 5 cm);
infected wounds at presentation; having visited a physician’s office ¿ 8 h after the injury;
wounds with skin loss requiring plastic surgery; or patients with immune deficiency,
using immunosuppressive agents, or with autoimmune disorders or diabetes; refusal to
give consent
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Chen 2016 (Continued)
Interventions Group A (n = 335 participants): standard care - sterilised dressings
Group B (n = 123 participants): polyvinyl alcohol shrink formaldehyde bubble dressing
+ NPWT set at 125 mm Hg
Group C (n = 128 participants): polyvinyl alcohol shrink formaldehyde bubble dressing
+ NPWT set at 75 mm Hg
Co-intervention: wounds were cleaned and disinfected. This was followed by debride-
ment and important tissue repair after which wounds were covered. All participants were
given rabies prophylactic active immunity and/or passive immunity, tetanus antitoxin
was also given where necessary. Drainage was also performed, however, removed 24-48
h before surgery. Antibiotics were administered only after wound infection occurred
Outcomes Primary review outcomes: wound infection*; time to clinical healing (defined as the
interval from being bitten to the wound achieving clinical healing)
Secondary review outcomes: none reported
*defined as the satisfaction of 1 of the following 3 major criteria: fever (body temperature
≥ 38°C), abscess, and lymphangitis, or 4/5 minor criteria: wound-associated erythema
that extended ¿ 3 cm from the edge of the wound, tenderness at the wound site, swelling
at the site, purulent drainage, and a white blood cell count in the peripheral blood of
12,000/mL
Notes The study authors declare no conflicts of interest. Funding source was not reported
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “All participants were subjected to
block randomisation…using a block ran-
dom digits table”
Comment: a block random digits table
used to ensure the randomisation
Allocation concealment (selection bias) Unclear risk Quote: see above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: no quote
Comment: no mention of blinding but
would not be possible to blind health pro-
fessionals to the different treatments so
without further detail considered high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: no quote
Comment: no mention of blinding in the
paper
Incomplete outcome data (attrition bias)
All outcomes
High risk Quote: no quote
Comment: 6 participants in the standard
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Chen 2016 (Continued)
care group without clarifying the reasons
vs 0 were lost to follow-up in the NPWT
group
Selective reporting (reporting bias) Unclear risk Quote: no quote
Comment: participants had an average of
4.6 wounds, which would usually result in
unit of analysis issues, however, wound in-
fection data suggest the unit of analysis was
the participants
Other bias Low risk Quote: no quote
Comment: there was a difference in num-
ber of participants with wounds inmultiple
locations, however, this is unlikely to have
introduced bias since the unit of randomi-
sation was the participant; no other areas
of potential risk were noted
Costa 2017
Methods 2-arm, multi-centre RCT
Conducted in 24 NHS hospitals in the UK
Follow-up: up to 12 months
Participants 625 participants (460 consenting and 165 not consenting) with open fracture of the
lower limb were recruited and randomised from July 2012-December 2015. Data only
collected on consenting participants (this process was used due to the patient population
often being unable to consent at the point of randomisation)
Inclusion criteria: aged ≥ 16 years; presented (or transferred) to a trial hospital within
72 h of injury; had sustained an open fracture of the lower limb graded as G/A 2 or
3. The treating surgeon determined the G/A grade at the end of surgical debridement
as per routine operative practice. Additionally the wound could not be closed primarily
after the first surgical debridement
Exclusion criteria: any contra-indications to anaesthesia such that the participant was
unfit for surgery; there was evidence that the participant was unable to adhere to trial
procedures or complete questionnaires, such as permanent cognitive impairment. G/A
grade 1 injuries were also excluded. In a small proportion of participants, this exclusion
criterion would only be determined after randomisation and emergency surgery had
taken place. These participants were withdrawn from the study and no participant-
identifiable data retained
Interventions Group A (n = 226 participants) NPWT. The dressing used an ’open-cell’ solid foam or
gauze and an adherent dressing. Exact details of dressing and pressure were left to the
discretion of the treating healthcare team.Most of the participants (74%) received pump
pressure of 125 mmHg, 17% participants did not and in 9.5% the pressure used is not
known. The majority of participants (77%) received continuous NPWT operation; 6%
received intermittent use and for 17% the type of use was not known
Group B (n = 234 participants) Usual care. Standard dressing (without NPWT) com-
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Costa 2017 (Continued)
prising a non-adhesive layer applied directly to the wound covered by a sealed dressing or
bandage. The exact details of the materials used were left to the discretion of the treating
surgeon as per routine care
All participants received a general or regional anaesthetic, wound debridement and frac-
ture treated with either internal or external fixation. After the initial operation, if the
open fracture wound could not be closed, patients were randomised to study groups
Both groups of participants then followed standard local post-opmanagement of patients
with an open fracture of the leg with an open wound. Normally this meant a second
operation between 48 and 72 h after the first, with further debridement performed and
the wounds closed or soft tissue reconstruction performed as necessary. Any further
dressing to open wounds followed the allocated treatment until definitive closure/cover
of the wound
Outcomes Primary review outcomes: proportion of wounds healed at 6 weeks; adverse events;
wound infection (unblinded assessment of superficial surgical site infection within 30
days and deep surgical site infection at 30 days, also blinded assessment of wound
infection using photographs at 6 weeks from recruitment); adverse events
Secondary review outcomes: health-related quality of life (EQ-5D, SF-12); pain; cost-
effectiveness
Notes Funded by the NIHR Health Technology Assessment programme
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “A computer-generated random al-
location sequence was generated and con-
trolled by York Clinical Trials Unit. The
unit of randomisation was the individual
patient on a 1:1 basis, stratified by trial cen-
tre and Gustilo and Anderson score. When
a patient entered the trial, non-identifi-
able details were logged on the secure, en-
crypted, web-based, randomisation system
and then the allocation was generated”
Allocation concealment (selection bias) Low risk Quote: from paper “Trial participants were
assigned to their treatment allocation in-
traoperatively at the end of initial surgery,
but before a wound dressing was applied.
All operating theatres included a computer
with internet access therefore, a secure, 24
hour, web-based randomisation systemwas
used to generate treatment allocation.”
Clarification from study authors that a cen-
tral randomisation system with indepen-
dent allocation was used
Comment: insufficient information
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Costa 2017 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “As the wound dressings were
clearly identifiable, it was not possible to
blind trial participants or clinical teams to
treatment allocation”
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Quote: “As the wound dressings were
clearly identifiable, it was not possible to
blind trial participants or clinical teams
to treatment allocation. However, outcome
assessment was undertaken by trained re-
search associates (nurse or research phys-
iotherapist) independent of the clinical
care team. For patient-reported outcomes
(disability, pain, quality of life, resource
use, other complications), trial participants
completed follow-up questionnaires them-
selves and these were returned directly to
the central trial office.”
Comment: assessment of wound healing
was done using photographs by indepen-
dent assessors unaware of treatment alloca-
tion
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk There was missing data for the healing and
infection outcomes (which were secondary
outcomes in the trial). The number of pre-
(NPWT = 85 vs standard care = 80) and
post-consent (NPWT= 14 vs standard care
= 15) withdrawals as well as deviations from
allocated treatment (8 NPWT vs 15 stan-
dard care participants crossed over to other
intervention group) was balanced between
groups
Selective reporting (reporting bias) Low risk Trial
registration available (ISRCTN33756652)
. All outcomes reported
Other bias Low risk Baseline characteristics appeared to be bal-
anced across groups; no other apparent bi-
ases
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Keskin 2008
Methods 2-arm RCT
Conducted in Turkey
Follow-up: 10 days
Participants 40 participants with lower extremity, non-diabetic, post-traumatic wounds
Inclusion criteria: age ≥ 18 years; had given written informed consent to participate;
were haemodynamically stable; well-orientated; and were able to co-operate in answering
the questions
Exclusion criteria: none stated, however, none of the participants had any other chronic
illnesses; none used mood modifying drugs or anxiolytics at the time of the study
Interventions Group A (n = 20 participants): standard moist wound care. After debridement wound
closure with standard moist gauze dressings that were changed daily
Group B (n = 20 participants): VAC. VAC black polyurethane foam was placed over
the wound after debridement, a VAC drape was placed over the foam and then pressure
was applied at 125 mmHg intermittently. Dressings were changed 3 times/week
Outcomes Primary review outcomes: none reported
Secondary review outcomes: none reported
Notes Funding source was not stated
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “They were randomly distributed
into two groups according to the way that
their wounds were treated”
Comment: insufficient information
Allocation concealment (selection bias) Unclear risk Quote: see above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “There was no blinding between
the two groups since the researcher could
see which dressing material was being used
on a particular wound during dressing
change”
Comment: no mention of blinding but
would not be possible to blind health pro-
fessionals to the different treatments so
without further detail considered high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: no quote
Comment: not stated
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Keskin 2008 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “Patients who had been discharged
before the 10th day were excluded from the
study and new patients enrolled.”
Comment: clarified the procedure of ex-
clusion
Selective reporting (reporting bias) Low risk Quote: no quote
Comment: study protocol was not avail-
able, however, all expected outcomes ap-
pear to have been reported
Other bias High risk Quote: no quote
Comment: the difference in frequency of
change of wound dressings may have re-
sulted in bias. The assignment of addi-
tional participants to study groups to re-
place those lost to follow-up may not have
been done at random
Ondieki 2012
Methods 2-arm RCT
Conducted in Kenyatta National Hospital orthopaedic and surgical wards, Kenya
Follow-up: unclear, however, study duration was 6 months
Participants 51 participants with 52 class IV wounds (1 participant in the gauze group was excluded
from analysis for smoking, however, 1 participant had 2 wounds)
Inclusion criteria: aged ¿ 12 years with class III or IV acute traumatic wounds and soft
tissue loss involving the full thickness of the skin and deeper of the lower limbs, injury
occurred ¡ 72 h prior to recruitment into study, undergone surgical toilet* to remove all
non-viable tissues and foreign bodies
Exclusion criteria: wounds with exposed major blood vessels or where haemostasis
has not been achieved, non-trauma wounds, smokers; diabetes mellitus, psychosis or
chronic renal failure; use of corticosteroids, chemotherapy or anticoagulants; refusal to
give consent
Interventions Group A (n = 25 wounds; 25 participants): gauze
GroupB (n = 26 wounds; 25 participants): NPWT - sterile standard foammanufactured
by Bobmil Inc
NPWT was stopped if there was a contraindication to continue with the treatment,
participant opted out or 100% granulation
Wounds were assessed 12 h after surgical toilet* using normal saline before dressing
was applied. Secured suction catheter at 125 mmHg was placed on gauze or foam and
dressing was changed every 72 h until the wound achieved full granulation. Regular dose
of analgesics with additional analgesia if required and prophylactic antibiotics
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Ondieki 2012 (Continued)
Outcomes Primary review outcomes: wound infection (defined as purulent discharge from the
wound site or positive culture of the wound)
Secondary review outcomes: pain based on numeric rating scale (combination of VAS
and VRS); time to full granulation
Notes Master degree thesis
*surgical toilet - involved thorough cleaning of wounds with normal saline under local
or general anaesthesia
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Randomization and allocation se-
quence was accomplished by generating
numbers from http://www.randomization.
com”
Comment: block randomisation with
computer-generated allocation sequence
Allocation concealment (selection bias) Unclear risk Quote: see above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “There was no blinding between
the two groups since the researcher could
see which dressing material was being used
on a particular wound during dressing
change”
Comment: no mention of performance
blinding but would not be possible to blind
health professionals to the different treat-
ments so without further detail considered
high risk
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Quote: “There was no blinding between
the two groups since the researcher could
see which dressing material was being used
on a particular wound during dressing
change. This may cause bias in some obser-
vations like evaluation of pain”
Comment: this indicates that there was no
attempt to blind outcome assessment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: “One patient in the gauze group
was dropped from the study because he was
found smoking”
Comment: this is unlikely to cause bias
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Ondieki 2012 (Continued)
Selective reporting (reporting bias) Low risk Quote: no quote
Comment: all expected outcomes were re-
ported
Other bias Low risk Quote: no quote
Comment: no other apparent biases and
reporting was sufficient to be reasonably
confident that these were unlikely to be
present
Stannard 2009
Methods 2-arm RCT
Conducted in USA (Division of Orthopaedic surgery, University of Alabama*)
Follow-up: mean 28 (14-67) months
*Authors’ affiliation
Participants 59 randomised participants with 63 open fractures (1 participant omitted from analysis
due to below-knee amputation at initial surgical procedure). 54 participants (92%) had
Type III open fractures. Most participants had tibia, pilon or femur fractures
Inclusion criteria: severe open fracture that required serial surgical debridements; age
¿ 18 years and willingness to complete the treatment protocol and follow-up. Eligible
fractures included heavily contaminated type II fractures, type IIIA fractures that were
either heavily contaminated or had a remarkably severe soft tissue injury and all type IIB
or IIIC fractures according to G/A classification
Exclusion criteria: open fractures that could be closed after the initial surgery and did
not require serial debridements, an infected open fracture, a surgical incision that could
not be treated with NPWT, prisoners, pregnant women, patients or family members
who were unable or unwilling to sign study consent and anyone unable to complete the
treatment protocol including NPWT
Interventions Group A (n = 23 participants; 25 fractures): standard care - saline wet to moist dressings
Group B (n = 35 participants; 37 fractures): NPWT VAC dressing. Review authors
suggest likely use of GranuFOAM dressing, not confirmed with study authors
Co-interventions: all fractures had an irrigation, debridement and skeletal stabilisation
of the injury. This was followed by a second surgery that included irrigation and de-
bridement of the open fracture wound within 36-72 hours of the initial procedure. This
procedure was repeated as needed until all wounds achieved grade A status (abundant
granulation tissue and ready for closure or coverage). All participants received prophy-
lactic IV antibiotics (the type depended on the level of contamination) until 24 h after
closure or coverage
Outcomes Primary review outcomes: wound infection
Secondary review outcomes: health status: SF-36 (3, 6, 9 and 12 months); time to
readiness* for wound closure
*Wounds were considered ready for closure when they had abundant granulation tissue
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Stannard 2009 (Continued)
Notes Funded through a grant from Kinetics Concepts, Inc, San Antonio, TX (manufacturer
of VAC dressing)
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk Quote: “A random sampling algorithmwas
used to assign patients to receive either
NPWT or control in a 1:1 ratio
Comment: a random component was used
but there are insufficient details as to how
the sequence was derived
Allocation concealment (selection bias) Unclear risk Quote: see above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “All patients underwent identical
treatment protocols with the exception of
the dressing over the open fracture”
Comment: no mention of blinding but
would not be possible to blind health pro-
fessionals to the different treatments so
without further detail considered high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: no quote
Comment: no mention of blinding in the
paper
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: no quote
Comment: data for one participant were
omitted, however, this was not considered
sufficient to bias results
Selective reporting (reporting bias) High risk Quote: “Short Form 36 data were obtained
on our patients at the following time inter-
vals: injury, 3months, 6months, 9months,
12 months, and final follow-up.”
Comment: only data recorded at 3, 6 and
9 months were reported
Other bias Unclear risk Quote: “…a disproportionate number of
patients who are smokers randomising to
the study group” (Discussion section)
Comment: unclear what impact smoking
(7 vs 18) would have had on the outcomes
of interest
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Virani 2016
Methods 2-arm RCT
Conducted in India
Follow-up: 23 weeks ± 6 weeks
Participants 95 participants with open tibial fractures (2 participants excluded due to the need for
amputation). Most participants had Grade IIIA or IIIB fractures
Inclusion criteria: age≥ 18 years suffering from an open tibial fracture whowere willing
to be part of the trial; consent
Exclusion criteria: age ¡ 18; wounds that could be closed at the index surgery; those
not needing repeated debridements and dressings; reluctance to give consent; having
periarticular tibial fractures; needing amputations; wounds on which it would not be
possible to use NPWT. All Grade I and most of Grade II fractures had to be excluded
from the study as the wounds could be closed after debridement
Interventions Group A (n = 50 participants): standard care. Daily cleaning, dressing and debridement
Group B (n = 43 participants): VAC dressing and negative pressure of about 125 mmHg
applied intermittently. The wound was opened every fourth day for reapplication of
dressing
All participants underwent debridement and received perioperative antibiotic coverage.
These antibiotics were continued post-operatively. Serial irrigation and debridement was
continued till the wounds were ready for closure or coverage
Outcomes Primary review outcomes: wound infection*
Secondary review outcomes: time to closure or coverage surgery
*Signs of acute wound infection like pyrexia, raised total leucocyte count and local signs
like pus discharge from the wound with erythema of skin edges within 1 week of primary
debridement was considered to have an acute infection. Deep infections included cases
developing features of chronic osteomyelitis like a discharging sinus, fixed puckered
overlying soft tissue and radiological changes consistent with chronic osteomyelitis
Notes Funding source was not stated.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Quote: “Using a random number genera-
tor, 50 patients were allotted to the control
group and 43 to the group receiving nega-
tive pressure therapy”
Comment: a random component used
Allocation concealment (selection bias) Unclear risk Quote: see above
Comment:methods of allocation conceal-
ment unclear
Blinding of participants and personnel
(performance bias)
All outcomes
High risk Quote: “There was no blinding between
the two groups since the researcher could
see which dressing material was being used
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Virani 2016 (Continued)
on a particular wound during dressing
change”
Comment: no mention of blinding but
would not be possible to blind health pro-
fessionals to the different treatments so
without further detail considered high risk
Blinding of outcome assessment (detection
bias)
All outcomes
Unclear risk Quote: no quote
Comment: not stated
Incomplete outcome data (attrition bias)
All outcomes
Low risk Quote: no quote
Comment: of the 95 recruited participants
there were two participants that were ex-
cluded for needing amputations. It is not
clear which group these participants be-
longed to, however, this was not considered
a source of bias
Selective reporting (reporting bias) Unclear risk Quote: no quote
Comment: study protocol not available,
however, all expected outcomes appear to
have been reported
Other bias Low risk Quote: no quote
Comment: no other apparent biases, and
reporting was sufficient to be reasonably
confident that these were unlikely to be
present
G/A: Gustilo and Anderson; IV: intravenous; NHS: National Health Service; NPWT: negative pressure wound therapy; RCT: ran-
domised controlled trial; VAC: Vacuum-Assisted Closure Device; VAS: visual analogue scale; VRS: visual rating scale
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Braakenburg 2006 Ineligible patient population
Brown 2012 Ineligible study design
Colom 2006 Ineligible intervention
Dorafshar 2012 Ineligible patient population
46Negative pressure wound therapy for open traumatic wounds (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
Fleischmann 1993 Ineligible study design
Fleischmann 1995 Ineligible study design
Jeschke 2004 Ineligible intervention
Lesiak 2013 Ineligible study design
MAS 2006 Ineligible study design
Moisidis 2004 Ineligible patient population
Mouës 2004 Ineligible patient population
Mouës 2005 Ineligible patient population
Mouës 2008 Ineligible patient population
Mouës 2007 Ineligible patient population
Rahmanian-Schwarz 2012 Ineligible patient population
Rovee 2004 Ineligible study design
Stannard 2006 Ineligible wound type
Stannard 2012 Ineligible wound type
Ubbink 2008 Ineligible study design
Vikatmaa 2008 Ineligible study design
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D A T A A N D A N A L Y S E S
Comparison 1. NPWT 125 mmHg versus standard care in open fracture wounds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Wounds healed (short-term
follow-up)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
2 Wound infection (short- to
medium-term follow-up)
4 596 Risk Ratio (M-H, Random, 95% CI) 0.48 [0.20, 1.13]
3 Wound infection: sensitivity
analysis
4 701 Risk Ratio (M-H, Random, 95% CI) 0.49 [0.19, 1.27]
4 Health-related quality of life at
12 months
1 Mean Difference (IV, Random, 95% CI) Subtotals only
4.1 SF-12 (Physical
Component Score)
1 329 Mean Difference (IV, Random, 95% CI) -0.5 [-4.08, 3.08]
4.2 EQ-5D Utility 1 364 Mean Difference (IV, Random, 95% CI) -0.01 [-0.08, 0.06]
Comparison 2. NPWT 125 mmHg versus standard care in other open traumatic wounds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Wound infection (follow-up
unclear)
2 509 Risk Ratio (M-H, Random, 95% CI) 0.61 [0.31, 1.18]
2 Pain (short-term follow-up) 1 Mean Difference (IV, Fixed, 95% CI) Subtotals only
Comparison 3. NPWT 75 mmHg versus standard care in other open traumatic wounds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Wound infection (follow-up
unclear)
1 463 Risk Ratio (M-H, Random, 95% CI) 0.44 [0.17, 1.10]
48Negative pressure wound therapy for open traumatic wounds (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Comparison 4. Different pressures of NPWT in other open traumatic wounds
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Wound infection (follow-up
unclear)
1 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 125 mmHg versus 75
mmHg
1 251 Risk Ratio (M-H, Fixed, 95% CI) 1.04 [0.31, 3.51]
Analysis 1.1. Comparison 1 NPWT 125 mmHg versus standard care in open fracture wounds, Outcome 1
Wounds healed (short-term follow-up).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 1 NPWT 125 mmHg versus standard care in open fracture wounds
Outcome: 1 Wounds healed (short-term follow-up)
Study or subgroup NPWT 125 mmHg Standard care Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Costa 2017 (1) 91/226 93/234 1.01 [ 0.81, 1.27 ]
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT 125 mmHg Favours standard care
(1) Photographic assessment
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Analysis 1.2. Comparison 1 NPWT 125 mmHg versus standard care in open fracture wounds, Outcome 2
Wound infection (short- to medium-term follow-up).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 1 NPWT 125 mmHg versus standard care in open fracture wounds
Outcome: 2 Wound infection (short- to medium-term follow-up)
Study or subgroup NPWT 125 mmHg Standard care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Arti 2016 3/45 4/45 20.2 % 0.75 [ 0.18, 3.16 ]
Costa 2017 (1) 27/175 31/180 40.3 % 0.90 [ 0.56, 1.44 ]
Stannard 2009 2/35 7/23 19.5 % 0.19 [ 0.04, 0.83 ]
Virani 2016 2/43 11/50 20.0 % 0.21 [ 0.05, 0.90 ]
Total (95% CI) 298 298 100.0 % 0.48 [ 0.20, 1.13 ]
Total events: 34 (NPWT 125 mmHg), 53 (Standard care)
Heterogeneity: Tau2 = 0.42; Chi2 = 6.86, df = 3 (P = 0.08); I2 =56%
Test for overall effect: Z = 1.68 (P = 0.093)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT 125 mmHg Favours standard care
(1) Photographic assessment
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Analysis 1.3. Comparison 1 NPWT 125 mmHg versus standard care in open fracture wounds, Outcome 3
Wound infection: sensitivity analysis.
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 1 NPWT 125 mmHg versus standard care in open fracture wounds
Outcome: 3 Wound infection: sensitivity analysis
Study or subgroup NPWT 125 mmHg Standard care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Arti 2016 3/45 4/45 20.9 % 0.75 [ 0.18, 3.16 ]
Costa 2017 (1) 51/226 52/234 38.0 % 1.02 [ 0.72, 1.43 ]
Stannard 2009 2/35 7/23 20.3 % 0.19 [ 0.04, 0.83 ]
Virani 2016 2/43 11/50 20.8 % 0.21 [ 0.05, 0.90 ]
Total (95% CI) 349 352 100.0 % 0.49 [ 0.19, 1.27 ]
Total events: 58 (NPWT 125 mmHg), 74 (Standard care)
Heterogeneity: Tau2 = 0.59; Chi2 = 8.84, df = 3 (P = 0.03); I2 =66%
Test for overall effect: Z = 1.47 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT 125 mmHg Favours standard care
(1) Photographic assessment
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Analysis 1.4. Comparison 1 NPWT 125 mmHg versus standard care in open fracture wounds, Outcome 4
Health-related quality of life at 12 months.
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 1 NPWT 125 mmHg versus standard care in open fracture wounds
Outcome: 4 Health-related quality of life at 12 months
Study or subgroup NPWT 125 mmHg Standard care
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
1 SF-12 (Physical Component Score)
Costa 2017 (1) 154 32.2 (17.4) 175 32.7 (15.5) 100.0 % -0.50 [ -4.08, 3.08 ]
Subtotal (95% CI) 154 175 100.0 % -0.50 [ -4.08, 3.08 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.27 (P = 0.78)
2 EQ-5D Utility
Costa 2017 172 0.55 (0.33) 192 0.56 (0.32) 100.0 % -0.01 [ -0.08, 0.06 ]
Subtotal (95% CI) 172 192 100.0 % -0.01 [ -0.08, 0.06 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
-100 -50 0 50 100
Favours standard care Favours NPWT 125 mmHg
(1) EQ-5D VAS (0 to 100) at 12 months
52Negative pressure wound therapy for open traumatic wounds (Review)
Copyright © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 2.1. Comparison 2 NPWT 125 mmHg versus standard care in other open traumatic wounds,
Outcome 1 Wound infection (follow-up unclear).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 2 NPWT 125 mmHg versus standard care in other open traumatic wounds
Outcome: 1 Wound infection (follow-up unclear)
Study or subgroup NPWT Standard care Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chen 2016 5/123 30/335 51.0 % 0.45 [ 0.18, 1.14 ]
Ondieki 2012 6/26 7/25 49.0 % 0.82 [ 0.32, 2.11 ]
Total (95% CI) 149 360 100.0 % 0.61 [ 0.31, 1.18 ]
Total events: 11 (NPWT), 37 (Standard care)
Heterogeneity: Tau2 = 0.0; Chi2 = 0.83, df = 1 (P = 0.36); I2 =0.0%
Test for overall effect: Z = 1.48 (P = 0.14)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT Favours standard care
Analysis 2.2. Comparison 2 NPWT 125 mmHg versus standard care in other open traumatic wounds,
Outcome 2 Pain (short-term follow-up).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 2 NPWT 125 mmHg versus standard care in other open traumatic wounds
Outcome: 2 Pain (short-term follow-up)
Study or subgroup NPWT 125 mmHg Standard care
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Ondieki 2012 26 4.7 (0.9) 25 4.4 (1) 0.30 [ -0.22, 0.82 ]
Test for subgroup differences: Not applicable
-100 -50 0 50 100
Favours NPWT 125 mmHg Favours standard care
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Analysis 3.1. Comparison 3 NPWT 75 mmHg versus standard care in other open traumatic wounds,
Outcome 1 Wound infection (follow-up unclear).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 3 NPWT 75 mmHg versus standard care in other open traumatic wounds
Outcome: 1 Wound infection (follow-up unclear)
Study or subgroup Experimental Control Risk Ratio Weight Risk Ratio
n/N n/N
M-
H,Random,95%
CI
M-
H,Random,95%
CI
Chen 2016 5/128 30/335 100.0 % 0.44 [ 0.17, 1.10 ]
Total (95% CI) 128 335 100.0 % 0.44 [ 0.17, 1.10 ]
Total events: 5 (Experimental), 30 (Control)
Heterogeneity: not applicable
Test for overall effect: Z = 1.76 (P = 0.079)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT Favours standard care
Analysis 4.1. Comparison 4 Different pressures of NPWT in other open traumatic wounds, Outcome 1
Wound infection (follow-up unclear).
Review: Negative pressure wound therapy for open traumatic wounds
Comparison: 4 Different pressures of NPWT in other open traumatic wounds
Outcome: 1 Wound infection (follow-up unclear)
Study or subgroup NPWT 125 mmHg NPWT 75 mmHg Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 125 mmHg versus 75 mmHg
Chen 2016 5/123 5/128 100.0 % 1.04 [ 0.31, 3.51 ]
Subtotal (95% CI) 123 128 100.0 % 1.04 [ 0.31, 3.51 ]
Total events: 5 (NPWT 125 mmHg), 5 (NPWT 75 mmHg)
Heterogeneity: not applicable
Test for overall effect: Z = 0.06 (P = 0.95)
Test for subgroup differences: Not applicable
0.01 0.1 1 10 100
Favours NPWT 125 mmHg Favours NPWT 75 mmHg
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A D D I T I O N A L T A B L E S
Table 1. Data extraction table
Study Com-
parison
Time to
healing
data
%
wounds
healed
Wound
Infec-
tion
Adverse
events
%
wounds
closed
with
surgery
Time to
closure
or cov-
erage
surgery
Health-
related
quality
of life
Wound
recur-
rence
Mean
pain
scores
Cost ef-
fective-
ness
Arti
2016
Group
A
(n = 45):
conven-
tional
dress-
ings
Group
B
(n = 45):
NPWT
Not re-
ported
Not re-
ported
1 month
Deep in-
fection
Group
A: 4/45
Group
B: 3/45
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Chen
2016
Group
A (n =
335 par-
tici-
pants)
: Sstan-
dard care
-
sterilised
dress-
ings
Group
B (n
= 123
partici-
pants):
Ppolyvinyl
alcohol
shrink
formalde-
hyde
bubble
dress-
ing +
Time to
recovery
(which
the
study
au-
thors de-
fined as
time
from
surgery
to clini-
cal heal-
ing)
Results
were
stratified
by those
with and
without
infec-
tion.
The
unit of
Not re-
ported
Group
A: 30/
335
Group
B: 5/123
Group
C: 5/
128
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
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Table 1. Data extraction table (Continued)
NPWT
set at
125 mm
Hg
Group
C (n
= 128
partici-
pants):
Ppolyvinyl
alcohol
shrink
formalde-
hyde
bubble
dress-
ing +
NPWT
set at 75
mm Hg
data was
not pre-
sented.
It is not
clear if
there are
mean or
median
data al-
though
use of
the t-
test for
signif-
icance
testing
suggests
means
value
and SD
were
pre-
sented.
It is not
clear if
all par-
ticipants
healed
Time
to clini-
cal heal-
ing
(days)
Infected
Group
A: 19.2 ±
4.6
Group
B: 13.2 ±
2.1
Group
C: 12.7
± 2.3
Not in-
fected
Group
A: 15.6 ±
2.7
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Table 1. Data extraction table (Continued)
Group
B: 10.1 ±
2.3
Group
C: 10.5
± 1.9
Costa
2017
Con-
sent-
ing par-
ticipants
Group
A (n =
234):
standard
wound
dress-
ings
Group
B (n =
226):
NPWT
Not re-
ported
Blinded
assess-
ment at 6
weeks
Group
A: 93
Group
B: 91
Blinded
assess-
ment of
infection
vs. no in-
fection at
6 weeks
Group
A: 31/
180
Group
B: 27/
175
SSI re-
ported at
30 days
Deep
Group
A: 19/
235*
Group
B: 16/
225*
Superfi-
cial
Group
A: 33/
234*
Group
B: 35/
226*
Per-
sistent or
new SSI
be-
tween 30
day and
12
months
Group
Death
Group
A: 5/234
Group
B: 6/226
Follow-
ing are
reported
as num-
ber
of events
(not par-
ticipants
with
events)
Unre-
lated se-
rious ad-
verse
events
Group
A: 40
Group
B: 37
Further
surgery
related to
open
fracture
Group
A: 111
Group
B: 95
Other
post-op-
erative
compli-
cations
related
Not re-
ported
Not re-
ported
Quality
of
life at 12
months
(also pre-
sented at
3, 6, and
9
months.
As noted
in proto-
col latest
time
point is
extracted
for
review)
EQ-5D
Utility
(n: SD)
Group
A: 0.56
(192; 0.
32)
Group
B: 0.55
(172; 0.
33)
EQ-5D
VAS
(n; SD)
Group
A: 68.3
(190;
22.7)
Group
B: 67.7
(174;
Not re-
ported
Not re-
ported
Incre-
men-
tal mean
costs be-
tween
group A
and
B: GBP
£678
95% CIs
£-
1082 to
£2438
Incre-
mental
QALYs
between
Group A
and
B: 0.002
95% CIs
-0.054
to 0.059
ICER:
GBP£
267,910
Prob-
ablity of
NPWT
being
cost ef-
fective at
follow-
ing
thresh-
olds of
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Table 1. Data extraction table (Continued)
A: 16/
234*
Group
B: 12/
226*
*calcu-
lated by
review
authors
based on
% values
given in
report
to trial
wound
(soft
tissue;
neu-
rovas-
cular;
Ppain;
DVT;
Oother)
Group
A: 43
Group
B: 39
24.1)
SF-12
PCS
(n: SD)
Group
A: 32.7
(175;
15.5)
Group
B: 32.2
(154;
17.4)
SF-12
MCS
(n: SD)
Group
A: 44.3
(175; 8.
2)
Group
B: 44.7
(154; 8.
4)
cost per
QALY:
£GBP
15,000:
25%
£GBP
20,000:
24%
£GBP
30,000:
27%
Keskin
2008
Group
A (n =20
partici-
pants):
standard
moist
wound
care
Group
B (n =20
partici-
pants):
NPWT
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
Ondieki
2012
Group
A (n =25
wounds;
25 par-
tici-
pants):
gauze
Group
B (n =26
wounds;
25 par-
Not re-
ported
Not re-
ported
All infec-
tions
Group
A: 7/25
Group
B: 6/25
No com-
plica-
tions
Not re-
ported
Time
to 100%
granula-
tion
Group
A: 8.4 ±
3.5
Group
B: 8.1 ±
2.4
Not re-
ported
Not re-
ported
Group
A: 4.4 ±
1
Group
B: 4.7 ±
0.9
Not re-
ported
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Table 1. Data extraction table (Continued)
tici-
pants)
: NPWT
- sterile
standard
Bobmil
foam
Stan-
nard
2009
Group
A (n =23
partici-
pants;
25 frac-
tures):
stan-
dard care
(saline
wet
to moist
dress-
ings)
Group
B (n =35
partici-
pants;
37 frac-
tures):
NPWT
Not re-
ported
Not re-
ported
*Acute
infection
Group
A: 2/23
Group
B: 0/35
*Deep
infection
(Mean
11 weeks
after dis-
charge)
Group
A: 5/23
Group
B: 2/35
*Data
treated
as being
from
different
partic-
ipants,
that is,
patients
who had
acute in-
fection
were
assumed
to have
been
different
from
those
who had
deep in-
fection
Not re-
ported
Not re-
ported
Group
A: mean
3.2 days
(range 2
to 9)
Group
B: mean
4.0 days
(range 2
to 11)
SF-
36 PCS
Score
Mean
(95%
CI)
3
months
post in-
jury
Group
A: 32.4
(28.7 to
36)
Group
B: 43.8
(35.8 to
51.7)
(P = 0.
013)
6
months
post in-
jury
Group
A: 33.9
(28.8 to
39)
Group
B: 42.8
(35.1 to
49.9)
(P = 0.
049)
9
months
post in-
Not re-
ported
Not re-
ported
Not re-
ported
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Table 1. Data extraction table (Continued)
jury
Group
A: 27.6
(21.8 to
33.4)
Group
B:
57 (41.6
to 72.4)
(P = 0.
005)
Virani
2016
Group
A (n =50
partici-
pants):
standard
care.
Daily
clean-
ing,
dress-
ing and
debride-
ment
Group
B (n
= 43
partici-
pants):
vacuum
assisted
closure
(VAC)
dressing
and
negative
pressure
of about
125
mmHg
Not re-
ported
Not re-
ported
Acute
Group
A: 2/50
Group
B: 0/43
Deep
Group
A: 9/50
Group
B: 2/43
Not re-
ported
Not re-
ported
Group
A: 9.8
(SD not
re-
ported)
Group
B: 8.3
(SD not
re-
ported)
Not re-
ported
Not re-
ported
Not re-
ported
Not re-
ported
PCS - Physical Component Score
SD - Standard deviation
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A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Wounds Specialised Register
1 MESH DESCRIPTOR Wounds, Penetrating EXPLODE ALL AND INREGISTER
2 MESH DESCRIPTOR Lacerations EXPLODE ALL AND INREGISTER
3 MESH DESCRIPTOR Fractures, Open EXPLODE ALL AND INREGISTER
4 (laceration* or gunshot or gun shot or stab or stabbing or stabbed or (open near3 fracture*)) AND INREGISTER
5 (traumatic wound* or acute wound*) AND INREGISTER
6 (mechanical trauma or polytrauma) AND INREGISTER
7 ((blast or crush or avulsion) near2 injur*) AND INREGISTER
8 #1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7
9 MESH DESCRIPTOR Negative-Pressure Wound Therapy EXPLODE ALL AND INREGISTER
10 MESH DESCRIPTOR Suction EXPLODE ALL AND INREGISTER
11 MESH DESCRIPTOR Vacuum EXPLODE ALL AND INREGISTER
12 (negative pressure or negative-pressure or TNP or NPWT) AND INREGISTER
13 (sub-atmospheric or subatmospheric) AND INREGISTER
14 ((seal* near2 surface*) or (seal* near2 aspirat*)) AND INREGISTER
15 (wound near2 suction*) AND INREGISTER
16 (wound near5 drainage) AND INREGISTER
17 ((foam near2 suction) or (suction near2 dressing*)) AND INREGISTER
18 (vacuum assisted closure or VAC) AND INREGISTER
19 ((vacuum near2 therapy) or (vacuum near2 dressing*) or (vacuum near2 seal*) or (vacuum near2 closure) or (vacuum near2
compression) or (vacuum near2 pack*) or (vacuum near2 drainage) or (suction* near2 drainage)) AND INREGISTER
20 #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19
21 #20 AND #8
The Cochrane Central Register of Controlled Clinical Trials (CENTRAL)
#1 MeSH descriptor: [Wounds, Penetrating] explode all trees
#2 MeSH descriptor: [Lacerations] explode all trees
#3 MeSH descriptor: [Fractures, Open] explode all trees
#4 (laceration* or gunshot or “gun shot” or “stab” or stabbing or stabbed or (open near/3 fracture*)):ti,ab,kw
#5 (traumatic next wound*) or (acute next wound*):ti,ab,kw
#6 (“mechanical trauma” or polytrauma):ti,ab,kw
#7 ((blast or crush or avulsion) next injur*):ti,ab,kw
#8 {or #1-#7}
#9 MeSH descriptor: [Negative-Pressure Wound Therapy] explode all trees
#10 MeSH descriptor: [Suction] explode all trees
#11 MeSH descriptor: [Vacuum] explode all trees
#12 (“negative pressure” or negative-pressure or TNP or NPWT):ti,ab,kw
#13 (sub-atmospheric or subatmospheric):ti,ab,kw
#14 ((seal* next surface*) or (seal* next aspirat*)):ti,ab,kw
#15 (wound near/3 suction*):ti,ab,kw
#16 (wound near/3 drainage):ti,ab,kw
#17 ((foam near suction) or (suction near dressing*)):ti,ab,kw
#18 (“vacuum assisted closure” or VAC):ti,ab,kw
#19 ((vacuum near therap*) or (vacuum near dressing*) or (vacuum near seal*) or (vacuum near closure) or (vacuum near compression)
or (vacuum near pack*) or (vacuum near drainage) or (suction* near drainage)):ti,ab,kw
#20 {or #9-#19}
#21 {and #8, #20} in Trials
Ovid MEDLINE
1 exp Wounds, Penetrating/
2 exp Lacerations/
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3 exp Fractures, Open/
4 (laceration* or gunshot or gun shot or stab or stabbing or stabbed or (open adj3 fracture*)).tw.
5 (traumatic wound* or acute wound*).tw.
6 (mechanical trauma or polytrauma).tw.
7 ((blast or crush or avulsion) adj injur*).tw.
8 or/1-7
9 exp Negative-Pressure Wound Therapy/
10 exp Suction/
11 exp Vacuum/
12 (negative pressure or negative-pressure or TNP or NPWT).tw.
13 (sub-atmospheric or subatmospheric).tw.
14 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
15 (wound adj2 suction*).tw.
16 (wound adj5 drainage).tw.
17 ((foam adj suction) or (suction adj dressing*)).tw.
18 (vacuum assisted closure or VAC).tw.
19 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
20 or/9-19
21 and/8,20
22 randomized controlled trial.pt.
23 controlled clinical trial.pt.
24 randomi?ed.ab.
25 placebo.ab.
26 clinical trials as topic.sh.
27 randomly.ab.
28 trial.ti.
29 or/22-28
30 exp animals/ not humans.sh.
31 29 not 30
32 21 and 31
Ovid Embase
1 exp penetrating trauma/
2 exp laceration/
3 exp open fracture/
4 (laceration* or gunshot or gun shot or stab or stabbing or stabbed or (open adj3 fracture*)).tw.
5 (traumatic wound* or acute wound*).tw.
6 (mechanical trauma or polytrauma).tw.
7 ((blast or crush or avulsion) adj injur*).tw.
8 or/1-7
9 exp vacuum assisted closure/
10 exp suction/
11 exp vacuum/
12 (negative pressure or negative-pressure or TNP or NPWT).tw.
13 (sub-atmospheric or subatmospheric).tw.
14 ((seal* adj surface*) or (seal* adj aspirat*)).tw.
15 (wound adj2 suction*).tw.
16 (wound adj5 drainage).tw.
17 ((foam adj suction) or (suction adj dressing*)).tw.
18 (vacuum assisted closure or VAC).tw.
19 ((vacuum adj therapy) or (vacuum adj dressing*) or (vacuum adj seal*) or (vacuum adj closure) or (vacuum adj compression) or
(vacuum adj pack*) or (vacuum adj drainage) or (suction* adj drainage)).tw.
20 or/9-19
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21 and/8,20
22 Randomized controlled trials/
23 Single-Blind Method/
24 Double-Blind Method/
25 Crossover Procedure/
26 (random* or factorial* or crossover* or cross over* or cross-over* or placebo* or assign* or allocat* or volunteer*).ti,ab.
27 (doubl* adj blind*).ti,ab.
28 (singl* adj blind*).ti,ab.
29 or/22-28
30 exp animals/ or exp invertebrate/ or animal experiment/ or animal model/ or animal tissue/ or animal cell/ or nonhuman/
31 human/ or human cell/
32 and/30-31
33 30 not 32
34 29 not 33
35 21 and 34
EBSCO CINAHL Plus
S35 S21 AND S34
S34 S22 OR S23 OR S24 OR S25 OR S26 OR S27 OR S28 OR S29 OR S30 OR S31 OR S32 OR S33
S33 TI allocat* random* or AB allocat* random*
S32 MH “Quantitative Studies”
S31 TI placebo* or AB placebo*
S30 MH “Placebos”
S29 TI random* allocat* or AB random* allocat*
S28 MH “Random Assignment”
S27 TI randomi?ed control* trial* or AB randomi?ed control* trial*
S26 AB ( singl* or doubl* or trebl* or tripl* ) and AB ( blind* or mask* )
S25 TI ( singl* or doubl* or trebl* or tripl* ) and TI ( blind* or mask* )
S24 TI clinic* N1 trial* or AB clinic* N1 trial*
S23 PT Clinical trial
S22 MH “Clinical Trials+”
S21 S9 AND S20
S20 S10 OR S11 OR S12 OR S13 OR S14 OR S15 OR S16 OR S17 OR S18 OR S19
S19 (MH “Negative Pressure Wound Therapy”)
S18 (MH “Suction+”)
S17 (MH “Vacuum”)
S16 TI ( (negative pressure or negative-pressure or TNP) ) OR AB ( (negative pressure or negative- pressure or TNP) )
S15 TI ( (sub-atmospheric or subatmospheric) ) OR AB ( (sub-atmospheric or subatmospheric) )
S14 TI ( (seal* N1 surface* or seal* N1 aspirat* ) ) OR AB ( (seal* N1 surface* or seal* N1 aspirat*) )
S13 TI (wound N2 suction*) OR AB (wound N2 suction*)
S12 TI ( (foam suction or suction dressing*) ) OR AB ( (foam suction or suction dressing*) )
S11 TI ( (vacuum assisted closure or VAC) ) OR AB ( (vacuum assisted closure or VAC) )
S10 TI ( vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack or vacuum
drainage ) OR AB ( vacuum therapy or vacuum dressing* or vacuum seal* or vacuum closure or vacuum compression or vacuum pack
or vacuum drainage )
S9 S1 OR S2 OR S3 OR S4 OR S5 OR S6 OR S7 OR S8
S8 TX ((blast or crush or avulsion) N1 injur*)
S7 TX (mechanical trauma or polytrauma)
S6 TX (traumatic wound* or acute wound*)
S5 TX (laceration* or gunshot or gun shot or stab or stabbing or stabbed or (open N3 fracture*))
S4 (MH “Trauma+”) AND ( (MH “Wounds and Injuries+”) )
S3 (MH “Fractures, Open”)
S2 (MH “Tears and Lacerations+”)
S1 (MH “Wounds, Penetrating+”)
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US National Institutes of Health Ongoing Trials Register (ClinicalTrials.gov)
Negative pressure wound therapy
Topical pressure therapy
Vacuum therapy
World Health Organization International Clinical Trials Registry Platform
Negative pressure wound therapy
Topical pressure therapy
Vacuum therapy
Appendix 2. Risk of bias assessment (individually randomised controlled trials)
1 Assessment of risk of bias (individually randomised controlled trials)
1. Was the allocation sequence randomly generated?
Low risk of bias
The investigators describe a random component in the sequence generation process such as: referring to a random number table; using
a computer random number generator; coin tossing; shuffling cards or envelopes; throwing dice; drawing of lots.
High risk of bias
The investigators describe a non-random component in the sequence generation process. Usually, the description would involve some
systematic, non-random approach, for example: sequence generated by odd or even date of birth; sequence generated by some rule
based on date (or day) of admission; sequence generated by some rule based on hospital or clinic record number.
Unclear
Insufficient information about the sequence generation process to permit judgement of low or high risk of bias.
2. Was the treatment allocation adequately concealed?
Low risk of bias
Participants and investigators enrolling participants could not foresee assignment because one of the following, or an equivalent
method, was used to conceal allocation: central allocation (including telephone, web-based and pharmacy-controlled randomisation);
sequentially numbered drug containers of identical appearance; sequentially numbered, opaque, sealed envelopes.
High risk of bias
Participants or investigators enrolling participants could possibly foresee assignments and thus introduce selection bias, such as allocation
based on: use of an open random allocation schedule (e.g. a list of random numbers); assignment envelopes without appropriate
safeguards (e.g. envelopes were unsealed, non-opaque or not sequentially numbered); alternation or rotation; date of birth; case record
number; any other explicitly unconcealed procedure.
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Unclear
Insufficient information to permit judgement of low or high risk of bias. This is usually the case if the method of concealment is not
described or not described in sufficient detail to allow a definite judgement, for example if the use of assignment envelopes is described,
but it remains unclear whether envelopes were sequentially numbered, opaque and sealed.
3. Blinding - was knowledge of the allocated interventions adequately prevented during the study?
Low risk of bias
Any one of the following.
• No blinding, but the review authors judge that the outcome and the outcome measurement were not likely to be influenced by
lack of blinding.
• Blinding of participants and key study personnel ensured, and unlikely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, but outcome assessment was blinded and the non-blinding of
others unlikely to introduce bias.
High risk of bias
Any one of the following.
• No blinding or incomplete blinding, and the outcome or outcome measurement was likely to be influenced by lack of blinding.
• Blinding of key study participants and personnel attempted, but likely that the blinding could have been broken.
• Either participants or some key study personnel were not blinded, and the non-blinding of others likely to introduce bias.
Unclear
Either of the following.
• Insufficient information to permit judgement of low or high risk of bias.
• The study did not address this outcome.
4. Were incomplete outcome data adequately addressed?
Low risk of bias
Any one of the following.
• No missing outcome data.
• Reasons for missing outcome data unlikely to be related to true outcome (for survival data, censoring unlikely to be introducing
bias).
• Missing outcome data balanced in numbers across intervention groups, with similar reasons for missing data across groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk not enough to have a
clinically relevant impact on the intervention effect estimate.
• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes not enough to have a clinically relevant impact on observed effect size.
• Missing data have been imputed using appropriate methods.
High risk of bias
Any one of the following.
• Reason for missing outcome data likely to be related to true outcome, with either imbalance in numbers or reasons for missing
data across intervention groups.
• For dichotomous outcome data, the proportion of missing outcomes compared with observed event risk enough to induce
clinically relevant bias in intervention effect estimate.
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• For continuous outcome data, plausible effect size (difference in means or standardised difference in means) among missing
outcomes enough to induce clinically relevant bias in observed effect size.
• ‘As-treated’ analysis done with substantial departure of the intervention received from that assigned at randomisation.
• Potentially inappropriate application of simple imputation.
Unclear
Either of the following:
• Insufficient reporting of attrition/exclusions to permit judgement of low or high risk of bias (e.g. number randomised not stated,
no reasons for missing data provided).
• The study did not address this outcome.
5. Are reports of the study free of suggestion of selective outcome reporting?
Low risk of bias
Either of the following.
• The study protocol is available and all of the study’s pre-specified (primary and secondary) outcomes that are of interest in the
review have been reported in the pre-specified way.
• The study protocol is not available but it is clear that the published reports include all expected outcomes, including those that
were pre-specified (convincing text of this nature may be uncommon).
High risk of bias
Any one of the following.
• Not all of the study’s pre-specified primary outcomes have been reported.
• One or more primary outcomes are reported using measurements, analysis methods or subsets of the data (e.g. subscales) that
were not pre-specified.
• One or more reported primary outcomes were not pre-specified (unless clear justification for their reporting is provided, such as
an unexpected adverse effect).
• One or more outcomes of interest in the review are reported incompletely so that they cannot be entered in a meta-analysis.
• The study report fails to include results for a key outcome that would be expected to have been reported for such a study.
Unclear
Insufficient information to permit judgement of low or high risk of bias. It is likely that the majority of studies will fall into this category.
6. Other sources of potential bias
Low risk of bias
The study appears to be free of other sources of bias.
High risk of bias
There is at least one important risk of bias. For example, the study:
• had a potential source of bias related to the specific study design used; or
• has been claimed to have been fraudulent; or
• had some other problem.
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Unclear
There may be a risk of bias, but there is either:
• insufficient information to assess whether an important risk of bias exists; or
• insufficient rationale or evidence that an identified problem will introduce bias.
Appendix 3. Risk of bias (cluster-randomised controlled trials)
In cluster-randomised trials, particular biases to consider include: recruitment bias; baseline imbalance; loss of clusters; incorrect analysis;
and comparability with individually randomised trials.
• Recruitment bias can occur when individuals are recruited to the trial after the clusters have been randomised, as the knowledge
of whether each cluster is an ‘intervention’ or ‘control’ cluster could affect the types of participants recruited.
• Cluster-randomised trials often randomise all clusters at once, so lack of concealment of an allocation sequence should not
usually be an issue. However, because small numbers of clusters are randomised, there is a possibility of chance baseline imbalance
between the randomised groups, in terms of either the clusters or the individuals. Although not a form of bias as such, the risk of
baseline differences can be reduced by using stratified or pair-matched randomisation of clusters. Reporting of the baseline
comparability of clusters, or statistical adjustment for baseline characteristics, can help reduce concern about the effects of baseline
imbalance.
• Occasionally complete clusters are lost from a trial, and have to be omitted from the analysis. Just as for missing outcome data in
individually randomised trials, this may lead to bias. In addition, missing outcomes for individuals within clusters may also lead to a
risk of bias in cluster-randomised trials.
• Many cluster-randomised trials are analysed by incorrect statistical methods, not taking the clustering into account. Such
analyses create a ‘unit of analysis error’ and produce over-precise results (the standard error of the estimated intervention effect is too
small) and P values that are too small. They do not lead to biased estimates of effect. However, if they remain uncorrected, they will
receive too much weight in a meta-analysis.
• In a meta-analysis including both cluster- and individually randomised trials, or including cluster-randomised trials with
different types of clusters, possible differences between the intervention effects being estimated need to be considered. For example, in
a vaccine trial of infectious diseases, a vaccine applied to all individuals in a community would be expected to be more effective than if
the vaccine was applied to only half of the people. Another example is provided by a Cochrane Review of hip protectors. The cluster
trials showed large positive effect whereas individually randomised trials did not show any clear benefit. One possibility is that there
was a ‘herd effect’ in the cluster-randomised trials (which were often performed in nursing homes, where compliance with using the
protectors may have been enhanced). In general, such ‘contamination’ would lead to underestimates of effect. Thus, if an intervention
effect is still demonstrated despite contamination in those trials that were not cluster-randomised, a confident conclusion about the
presence of an effect can be drawn. However, the size of the effect is likely to be underestimated. Contamination and ‘herd effects’
may be different for different types of cluster.
WH A T ’ S N E W
Last assessed as up-to-date: 25 June 2018.
Date Event Description
8 September 2017 Amended We have changed the title by adding the word ’open’ to make clear the type of traumatic wounds
that are of interest in this review
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
Description of the condition: we added additional information to the Background section to highlight key wound types and provide
some more information on these.
Types of participants: we clarified that the focus of this review was traumatic wounds that were treated as open wounds prior to closure.
Types of outcome measures: we made a post hoc decision to assess wound infection as a primary outcome. This should have been
included in the protocol but was omitted in error. This is an important outcome from a clinical perspective and NPWT is used widely
with the aim of preventing wound infection. We also presented cost data; although it was not planned at protocol stage, exclusion of
this important outcome was an oversight. We removed incidence of compartment syndrome based on peer review comments.
Unit of analysis issues: there was one study where the unit of analysis (25 versus 26 wounds) was different from the unit of randomisation
(25 versus 25 participants). As we were unable to quantify the difference this would have made to the study findings we decided to use
the participants as the unit of analysis.
Data synthesis: we made the decision to treat trials that enrolled participants with open fracture wounds separately from trials enrolling
participants with other types of traumatic wounds. This decision was made on clinical advice following the publication of the protocol.
We analysed data for NPWT 125 mmHg and NPWT 75 mmHg separately, as they were considered different doses of the treatment.
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